Patent Grant
10492780
The present invention relates generally to sutures, including self-retaining sutures and unidirectional self-retaining sutures, methods of manufacturing the sutures, and their uses in wound repair and surgical procedures.
Wound closure devices such as sutures, staples and tacks have been widely used in superficial and deep surgical procedures in humans and animals for closing wounds, repairing traumatic injuries or defects, joining tissues together (bringing severed tissues into approximation, closing an anatomical space, affixing single or multiple tissue layers together, creating an anastomosis between two hollow/luminal structures, adjoining tissues, attaching or reattaching tissues to their proper anatomical location), attaching foreign elements to tissues (affixing medical implants, devices, prostheses and other functional or supportive devices), and for repositioning tissues to new anatomical locations (repairs, tissue elevations, tissue grafting and related procedures) to name but a few examples.
Sutures are often used as wound closure devices. Sutures typically consist of a filamentous suture thread attached to a needle with a sharp point. Suture threads can be made from a wide variety of materials including bioabsorbable (that break down completely in the body over time), or non-absorbable (permanent; non-degradable) materials. Absorbable sutures have been found to be particularly useful in situations where suture removal might jeopardize the repair or where the natural healing process renders the support provided by the suture material unnecessary after wound healing has been completed; as in, for example, completing an uncomplicated skin closure. Non-degradable (non-absorbable) sutures are used in wounds where healing may be expected to be protracted or where the suture material is needed to provide physical support to the wound for long periods of time; as in, for example, deep tissue repairs, high tension wounds, many orthopedic repairs and some types of surgical anastomosis. Also, a wide variety of surgical needles are available; the shape and size of the needle body and the configuration of the needle tip is typically selected based upon the needs of the particular application.
To use an ordinary suture, a suture needle is advanced through the desired tissue on one side of the wound and then through the adjacent side of the wound. The ends of the suture are then brought into proximity to one another and then held together, e.g., by tying a knot in the suture to hold the wound closed. Knot tying takes time and causes a range of complications, including, but not limited to (i) spitting, a condition where the suture, usually a knot, pushes through the skin after a subcutaneous closure), (ii) infection (bacteria are often able to attach and grow in the spaces created by a knot), (iii) bulk/mass (a significant amount of suture material left in a wound is the portion that comprises the knot), (iv) slippage (knots can slip or come untied), and (v) irritation (knots serve as a bulk “foreign body” in a wound). Suture loops associated with knot tying may lead to ischemia (knots can create tension points that can strangulate tissue and limit blood flow to the region) and increased risk of dehiscence or rupture at the surgical wound. Knot tying is also labor intensive and can comprise a significant percentage of the time spent closing a surgical wound. Additional operative procedure time is not only bad for the patient (complication rates rise with time spent under anesthesia), but it also adds to the overall cost of the operation (many surgical procedures are estimated to cost between $15 and $30 per minute of operating time).
Self-retaining sutures (including barbed sutures) differ from conventional sutures in that self-retaining sutures possess numerous tissue retainers (such as barbs) which anchor the self-retaining suture into the tissue following deployment and resist movement of the suture in a direction opposite to that in which the retainers face, thereby eliminating the need to tie knots to affix adjacent tissues together (a “knotless” closure). Knotless tissue-approximating devices having barbs have been previously described in, for example, U.S. Pat. No. 5,374,268, disclosing armed anchors having barb-like projections, while suture assemblies having barbed lateral members have been described in U.S. Pat. Nos. 5,584,859 and 6,264,675. Sutures having a plurality of barbs positioned along a greater portion of the suture are described in U.S. Pat. No. 5,931,855, which discloses a unidirectional barbed suture, and U.S. Pat. No. 6,241,747, which discloses a bidirectional barbed suture. Methods and apparatuses for forming barbs on sutures have been described in, for example, U.S. Pat. No. 6,848,152. Self-retaining systems for wound closure also result in better approximation of the wound edges, evenly distribute the tension along the length of the wound (reducing areas of tension that can break or lead to ischemia), decrease the bulk of suture material remaining in the wound (by eliminating knots) and reduce spitting (the extrusion of suture material—typically knots—through the surface of the skin). All of these features are thought to reduce scarring, improve cosmesis, and increase wound strength relative to wound closures using plain sutures or staples. Thus, self-retaining sutures, because such sutures avoid knot tying, allow patients to experience an improved clinical outcome, and also save time and costs associated with extended surgeries and follow-up treatments. It is noted that all patents, patent applications and patent publications identified throughout are incorporated herein by reference in their entirety.
The ability of self-retaining sutures to anchor and hold tissues in place even in the absence of tension applied to the suture by a knot is a feature that also provides superiority over plain sutures. When closing a wound that is under tension, this advantage manifests itself in several ways: (i) self-retaining sutures have a multiplicity of retainers which can dissipate tension along the entire length of the suture (providing hundreds of “anchor” points that produce a superior cosmetic result and lessens the chance that the suture will “slip” or pull through) as opposed to knotted interrupted sutures which concentrate the tension at discrete points; (ii) complicated wound geometries can be closed (circles, arcs, jagged edges) in a uniform manner with more precision and accuracy than can be achieved with interrupted sutures; (iii) self-retaining sutures eliminate the need for a “third hand” which is often required for maintaining tension across the wound during traditional suturing and knot tying (to prevent “slippage” when tension is momentarily released during tying); (iv) self-retaining sutures are superior in procedures where knot tying is technically difficult, such as in deep wounds or laparoscopic/endoscopic procedures; and (v) self-retaining sutures can be used to approximate and hold the wound prior to definitive closure. As a result, self-retaining sutures provide easier handling in anatomically tight or deep places (such as the pelvis, abdomen and thorax) and make it easier to approximate tissues in laparoscopic/endoscopic and minimally invasive procedures; all without having to secure the closure via a knot. Greater accuracy allows self-retaining sutures to be used for more complex closures (such as those with diameter mismatches, larger defects or purse string suturing) than can be accomplished with plain sutures.
A self-retaining suture may be unidirectional, having one or more retainers oriented in one direction along the length of the suture thread; or bidirectional, typically having one or more retainers oriented in one direction along a portion of the thread, followed by one or more retainers oriented in another (often opposite) direction over a different portion of the thread (as described with barbed retainers in U.S. Pat. Nos. 5,931,855 and 6,241,747). Although any number of sequential or intermittent configurations of retainers are possible, a common form of self-retaining suture involves a needle at one end of a suture thread which has barbs having tips projecting “away” from the needle. Projecting “away” from the needle means that the tip of the retainer is further away from the needle and the portion of suture comprising the suture may be pulled more easily through tissue in the direction of the needle than in the opposite direction. Examples of various retainer configurations are described, for example, in U.S. Patent Application Publication Nos. 20040060409, issued as U.S. Pat. No. 8,100,940 on Jan. 24, 2012, 20040060410, issued as U.S. Pat. No. 8,795,332 on Aug. 5, 2014, 20080255611, issued as U.S. Pat. No. 8,915,943 on Dec. 23, 2014, and 20100087855, issued as U.S. Pat. No. 8,721,681 on May 13, 2014. In addition, self-retaining sutures having high-density retainer configurations are described in U.S. Patent Application Ser. No. 61/329,436.
Unidirectional self-retaining sutures and their uses have been described in various publications as mentioned above. Various unidirectional sutures with anchors, included anchors having loop elements, have been described in, for example, U.S. Patent Application Publication Nos. 20050267531, 20040060410, issued as U.S. Pat. No. 8,795,332 on Aug. 5, 2014, 20080255611, issued as U.S. Pat. No. 8,915,943 on Dec. 23, 2014, and 20100063540, issued as U.S. Pat. No. 10,016,196 on Jul. 10, 2018.
It is desirable in some applications to use unidirectional sutures which, at their trailing ends, have anchors configured to more effectively resist tensions and effectively preclude movement when the suture is deployed in tissue. It is also desirable in some applications to provide unidirectional sutures with anchors which, when deployed in tissue, have a minimal amount of anchor material entering the tissue as well as a minimal amount of anchor material remaining outside the tissue. Thus, it is desirable to provide improved unidirectional self-retaining sutures which have enhanced ability to anchor into the surrounding tissue, enhanced tissue holding capabilities, enhanced maximum load, and enhanced clinical performance.
The present invention provides improved unidirectional self-retaining sutures which have enhanced ability to anchor into the surrounding tissue, enhanced tissue holding capabilities, enhanced maximum load, and enhanced clinical performance.
In some embodiments of the present invention there is provided a self-retaining suture having a first end for penetrating tissue, an elongated suture body having a periphery, a first plurality of retainers on the periphery of the elongated body and oriented to the first end, the first plurality of retainers yielding toward the suture body during movement of the suture through tissue in a direction of deployment of the first end, and resisting movement of the suture, when in tissue, in a direction substantially opposite the direction of deployment of the first end, and a second end having a variable loop of variable circumference. The variable loop includes a fixed loop slidably engaging the elongated body so that the circumference of the variable loop may be changed by sliding the fixed loop along the elongated body, and the first end may pass through the variable loop to secure tissue as an anchor, the anchor preventing movement of the suture in the direction of deployment of the first end.
In some of these embodiments, at least one of the retainers of the first plurality may differ in configuration from other retainers of the first plurality.
In some of these embodiments, the cross section of the elongated suture body may be non-circular. In some embodiments in which the elongated suture body has a non-circular cross sections the cross section may be polygonal.
In some of these embodiments, the first end is adapted to penetrate tissue, while in other of these embodiments the first end is attached to a needle.
In some of these embodiments, the suture may have a surface feature on at least some of the periphery of the elongated body between the fixed loop and the first plurality of retainers, wherein the surface feature resists the sliding of the fixed loop over the surface feature. In some embodiments including surface features, the surface feature is disposed at least in the circumference of the variable loop.
In some embodiments having surface features, the suture feature may include roughening, dimpling, corrugations, ridges, or other textures, while in other such embodiments, the surface feature may include a second plurality of retainers which are oriented away from the first end and thus provide resistance to the sliding of the fixed loop over them. In some of those embodiments in which the surface features include a second plurality of retainers, at least some of the retainers of the second plurality may differ in configuration from retainers of the first plurality.
In some embodiments of the invention, the fixed loop has an inner transverse length which is at least about the same as the transverse length of the suture cross section, and may be up to ten times the transverse length of the suture cross section. In some of these embodiments, the inner transverse length of the fixed loop may be up to four times the transverse length of the suture cross section, while in other of these embodiments it may be up to three times the transverse length of the suture cross section. In yet other of these embodiments, the inner transverse length of the fixed loop may be about one-and-a-half times the transverse length of the suture cross section to about ten times transverse length of the suture cross section, while in others it may be about one-and-a-half times the transverse length of the suture cross section to about four times transverse length of the suture cross section. In yet others, it may be about twice the transverse length of the suture cross section to about three times the transverse length of the suture cross section.
In some embodiments of the invention, the fixed loop may include a grasp engagement element, or a visible or tactile marking.
In some embodiments of the present invention there is provided a self-retaining suture having a first end for penetrating tissue; an elongated suture body having a periphery and a cross section, the cross section having a transverse length; a first plurality of retainers on the periphery of the elongated body which are oriented to the first end, the first plurality of retainers yielding toward the suture body during movement of the suture through tissue in a direction of deployment of the first end, and resisting movement of the suture, when in tissue, in a direction substantially opposite the direction of deployment of the first end; a second end having a variable loop of variable circumference. The variable loop includes a fixed loop slidably engaging the elongated body so that the circumference of the variable loop may be changed by sliding the fixed loop along the elongated body, and the first end may pass through the variable loop to secure tissue as a third, anchoring loop in tissue, the anchoring loop preventing movement of the suture in the direction of deployment of the first end.
In some embodiments of the present invention there is provided a self-retaining suture having a first end for penetrating tissue; an elongated suture body having a periphery and a cross section, the cross section having a transverse length; a first plurality of retainers on the periphery of the elongated body which are oriented to the first end, the first plurality of retainers yielding toward the suture body during movement of the suture through tissue in a direction of deployment of the first end, and resisting movement of the suture, when in tissue, in a direction substantially opposite the direction of deployment of the first end; a second end having a slip knot, the slip knot including a loop of variable circumference so that the circumference of the loop may be changed by sliding the slip knot, and the first end may pass through the loop to secure tissue as an anchor for preventing movement of the suture in the direction of deployment of the first end.
In some embodiments of the present invention there is provided a self-retaining suture including a first end for penetrating tissue; an elongated suture body having a periphery and a cross section, the cross section having a transverse length; a first plurality of retainers on the periphery of the elongated body and oriented to the first end, the first plurality of retainers yielding toward the suture body during movement of the suture through tissue in a direction of deployment of the first end, and resisting movement of the suture, when in tissue, in a direction substantially opposite the direction of deployment of the first end; and a second end having a slip knot, the slip knot including a loop of variable circumference. Sliding the slip knot causes the circumference of the loop to change, and the first end may pass through the loop to secure tissue, thereby creating an anchoring loop in the tissue for preventing movement of the suture in the direction of deployment of the first end.
In some embodiments of the present invention there is provided a self-retaining suture that includes a first end for penetrating tissue; an elongated suture body having a periphery and a cross section, the cross section having a transverse length (tl); a first plurality of retainers on the periphery of the elongated body and oriented to the first end, the first plurality of retainers yielding toward the suture body during movement of the suture through tissue in a direction of deployment of the first end, and resisting movement of the suture, when in tissue, in a direction substantially opposite the direction of deployment of the first end; and a second end having a variable loop of variable circumference, wherein the variable loop includes a fixed loop having an inner transverse length (TL) and slidably engaging the elongated body, so that the circumference of the loop may be changed by sliding the slip knot. The ratio of TL:tl is about 1:1 to about 10:1. The first end may pass through the variable loop to secure tissue as an anchor for preventing movement of the suture in the direction of deployment of the first end.
In any embodiments of the self-retaining suture of the invention, the suture may additionally include a therapeutic agent.
The present invention yet further provides clinical methods and procedures enabled by such improved self-retaining sutures of small diameter.
In one embodiment there is provided a method of suturing tissue, the method comprising (a) providing a suture thread attached to a suture needle, a portion of the suture thread forming a loop having an adjustable circumference; (b) threading the needle through the loop; and (c) deploying the needle through tissue of a patient and approximating the tissue with the suture thread. Optionally, one or more of the following statements may further described this embodiment: the loop comprises suture thread and a fixed loop, the fixed loop having an opening through which the suture thread passes to thereby form the loop having an adjustable circumference; the fixed loop and any means by which the fixed loop is formed or attached to the suture thread, all lie on a surface of the tissue after the tissue has been completely approximated; the circumference of the loop is adjusted to a desired value prior to threading the needle through the loop; the circumference of the loop is adjusted to a desired value after threading the needle through the loop; the circumference of the loop is adjusted to a desired value in the range of 0.5 to 3 inches; the circumference of the loop is reduced to a desired value; the needle is passed into and then out of tissue at first and second locations, respectively, prior to being threaded through the loop; the suture thread comprises tissue retainers; the suture thread comprises cuts in the suture thread, the cuts forming the tissue retainers where optionally a cut lies in a single plane, or in two planes; a cut into the suture thread provides a barb where the barb is a tissue retainer, and there are a plurality of cuts in the suture thread; tissue retainers are present on a portion of the suture thread that forms the loop having an adjustable circumference; tissue retainers are absent from a portion of the loop having an adjustable circumference.
In another embodiment there is provided a method of anchoring a suture at a location on tissue of a patient, the method comprising: (a) providing a suture thread with an eyelet, the suture thread attached to a suture needle at a deployment end of the suture thread; (b) deploying the suture needle into tissue at the location, and then withdrawing the suture needle from tissue at an exit point; (c) passing the needle through a loop comprising suture thread, the loop having a variable circumference; (d) applying tension to the suture thread by pulling on the deployment end of the suture thread; (e) thereby providing an anchor on top of the tissue, the anchor comprising the eyelet, the loop and a portion of the suture thread, the anchor resisting movement of the suture thread in the direction of the deployment end of the suture thread.
The details of one or more embodiments are set forth in the description below. Other features, objects and advantages will be apparent from the description, the drawings, and the claims.
Features of the invention, and the nature and various advantages thereof will be apparent from the accompanying drawings and the following detailed description of various embodiments of the invention.
Definitions of certain terms that may be used herein include the following.
“Armed suture” refers to a suture having a suture needle at the suture deployment end.
“Braided suture” refers to a suture comprising a multifilamentary suture thread. The filaments in such suture threads are typically braided, twisted, or woven together.
“Degradable (also referred to as “biodegradable” or “bioabsorbable”) suture” refers to a suture which, after introduction into a tissue is broken down and absorbed by the body. Typically, the degradation process is at least partially mediated by, or performed in, a biological system. “Degradation” refers to a chain scission process by which a polymer chain is cleaved into bloomers and monomers. Chain scission may occur through various mechanisms, including, for example, by chemical reaction (e.g., hydrolysis, oxidation/reduction, enzymatic mechanisms or a combination or these) or by a thermal or photolytic process. Polymer degradation may be characterized, for example, using gel permeation chromatography (GPC), which monitors the polymer molecular mass changes during erosion and breakdown. Degradable suture material may include polymers such as polyglycolic acid, copolymers of glycolide and lactide, copolymers of trimethylene carbonate and glycolide with diethylene glycol (e.g., MAXON™, Tyco Healthcare Group), terpolymer composed of glycolide, trimethylene carbonate, and dioxanone (e.g., BIOSYN™[glycolide (60%), trimethylene carbonate (26%), and dioxanone (14%)], Tyco Healthcare Group), copolymers of glycolide, caprolactone, trimethylene carbonate, and lactide (e.g., CAPROSYN™, Tyco Healthcare Group). These sutures can be in either a braided multifilament form or a monofilament form. The polymers used in the present invention can be linear polymers, branched polymers or multi-axial polymers. Examples of multi-axial polymers used in sutures are described in U.S. Patent Application Publication Nos. 20020161168, now abandoned, 20040024169, issued as U.S. Pat. No. 7,026,437 on Apr. 11, 2006, and 20040116620, issued as U.S. Pat. No. 7,070,858 on Jul. 4, 2006. Sutures made from degradable suture material lose tensile strength as the material degrades.
Medical device” or “implant” refers to any object placed in the body for the purpose of restoring physiological function, reducing/alleviating symptoms associated with disease, and/or repairing/replacing damaged or diseased organs and tissues. While normally composed of biologically compatible synthetic materials (e.g., medical-grade stainless steel, titanium and other metals: polymers such as polyurethane, silicon, PLA, PLGA and other materials) that are exogenous, some medical devices and implants include materials derived from animals (e.g., “xenografts” such as whole animal organs; animal tissues such as heart valves; naturally occurring or chemically-modified molecules such as collagen, hyaluronic acid, proteins, carbohydrates and others), human donors (e.g., “allografts” such as whole organs; tissues such as bone grafts, skin grafts and others), or from the patients themselves (e.g., “autografts” such as saphenous vein grafts, skin grafts, tendon/ligament/muscle transplants). Medical devices that can be used in procedures in conjunction with the present invention include, but are not restricted to, orthopaedic implants (artificial joints, ligaments and tendons; screws, plates, and other implantable hardware), dental implants, intravascular implants (arterial and venous vascular bypass grafts, hemodialysis access grafts; both autologous and synthetic), skin grafts (autologous, synthetic), tubes, drains, implantable tissue bulking agents, pumps, shunts, sealants, surgical meshes (e.g., hernia repair meshes, tissue scaffolds), fistula treatments, spinal implants (e.g., artificial intervertebral discs, spinal fusion devices, etc.).
“Monofilament suture” refers to a suture comprising a monofilamentary suture thread.
“Needle attachment” refers to the attachment of a needle to a suture requiring same for deployment into tissue, and can include methods such as crimping, swaging, using adhesives, and so forth. The point of attachment of the suture to the needle is known as the swage.
“Needle diameter” refers to the diameter of a suture deployment needle at the widest point of that needle. While the term “diameter” is often associated with a circular periphery, it is to be understood herein to indicate a cross-sectional dimension associated with a periphery of any shape. The dimension is the longest dimension between two points on the periphery of the shape, i.e., the distance between the two points on the periphery that are the furthest from one another.
“Non-degradable (also referred to as “non-absorbable”) suture” refers to a suture comprising material that is not degraded by chain scission such as chemical reaction processes (e.g., hydrolysis, oxidation/reduction, enzymatic mechanisms or a combination of these) or by a thermal or photolytic process. Non-degradable suture material includes polyamide (also known as nylon, such as nylon 6 and nylon 6.6), polyester (e.g., polyethylene terephthlate), polytetrafluoroethylene (e.g., expanded polytetrafluoroethylene), polyether-ester such as polybutester (block copolymer of butylene terephthalate and polytetra methylene ether glycol), polyurethane, metal alloys, metal (e.g., stainless steel wire), polypropylene, polyethelene, silk, and cotton. Sutures made of non-degradable suture material are particularly suitable for applications in which the suture is meant to remain permanently or is meant to be physically removed from the body.
“Retainer configurations” refers to configurations of tissue retainers and can include features such as size, shape, surface characteristics, and so forth. These are sometimes also referred to as “barb configurations”.
“Self-retaining suture” refers to a suture that does not require a knot or anchor on at least one of its ends in order to maintain its position into which it is deployed during a surgical procedure. These may be monofilament sutures or braided sutures, and are positioned in tissue in two stages, namely deployment and affixation, and include at least one tissue retainer.
“Self-retaining system” refers to a self-retaining suture together with means for deploying the suture into tissue. Such deployment means include, without limitation, suture needles and other deployment devices as well as sufficiently rigid and sharp ends on the suture itself to penetrate tissue.
“Suture deployment end” refers to an end of the suture to be deployed into tissue. A deployment means such as a suture needle may be located at the suture deployment end, or the suture thread may be formed into a sufficiently sharp and rigid structure so as to penetrate tissue on its own, where this sharp and rigid structure is located at the suture deployment end of the suture.
“Suture diameter” refers to the diameter of the body of the suture when viewed in cross-section. While the term “diameter” is often associated with a circular periphery, it is to be understood herein to indicate a cross-sectional dimension (or distance, or length) associated with a periphery of any shape. For a non-circular shape, the diameter is the longest distance between any two points on the periphery of the cross section, which may also be referred to as the cross-sectional distance. The cross-sectional shape of the suture body or thread is viewed at a location along the suture where there are either no barbs, or the barbs that are present are pushed against the suture body so that they are flush with the surface of the suture body. In one embodiment, the suture body or thread has a generally circular cross-sectional shape. While the suture body may have a circular or generally circular cross-sectional shape, the cross-sectional shape may be non-circular, e.g., it may be polygonal, e.g., 3- (triangular), 4-, 5- or 6-sided (hexagonal) sided. The cross section of the suture body may have an oval, an ellipsoid, an oblong, or a semi-circular appearance. Suture sizing is based upon diameter. United States Pharmacopeia (“USP”) designation of suture size runs from 0 to 7 in the larger range and 1-0 to 11-0 in the smaller range; in the smaller range, the higher the value preceding the hyphenated zero, the smaller the suture diameter. Under the USP nomenclature system, the actual diameter of a suture will depend on the suture material, so that, by way of example, a suture of size 5-0 and made of collagen will have a diameter of 0.15 mm, while sutures having the same USP size designation but made of a synthetic absorbable material or a non-absorbable material will each have a diameter of 0.1 mm. The selection of suture size for a particular purpose depends upon factors such as the nature of the tissue to be sutured and the importance of cosmetic concerns; while smaller sutures may be more easily manipulated through tight surgical sites and are associated with less scarring, the tensile strength of a suture manufactured from a given material tends to decrease with decreasing size. It is to be understood that the sutures and methods of manufacturing sutures disclosed herein are suited to a variety of diameters, including without limitation 7, 6, 5, 4, 3, 2, 1, 0, 1-0, 2-0, 3-0, 4-0, 5-0, 6-0, 7-0, 8-0, 9-0, 10-0 and 11-0. It is to be understood that a variety of suture lengths may be used with the sutures described herein.
“Suture needle” refers to needles used to deploy sutures into tissue, which come in many different shapes, forms and compositions. There are two main types of needles, traumatic needles and atraumatic needles. Traumatic needles have channels or drilled ends (that is, holes or eyes) and are supplied separate from the suture thread and are threaded on site. Atraumatic needles are eyeless and are attached to the suture at the factory by swaging whereby the suture material is inserted into a channel at the blunt end of the needle which is then deformed to a final shape to hold the suture and needle together. As such, atraumatic needles do not require extra time on site for threading and the suture end at the needle attachment site is smaller than the needle body. In the traumatic needle the thread comes out of the needle's hole on both sides and often the suture rips the tissues to a certain extent as it passes through. Most modern sutures are swaged atraumatic needles. Atraumatic needles may be permanently swaged to the suture or may be designed to come off the suture with a sharp straight tug. These “pop-offs” are commonly used for interrupted sutures, where each suture is only passed once and then tied. For barbed sutures that are uninterrupted, these atraumatic needles would be ideal. Suture needles may also be classified according to their point geometry. For example, needles may be (i) “tapered” whereby the needle body is round and tapers smoothly to a point; (ii) “cutting” whereby the needle body is triangular and has sharpened cutting edge on the inside; (iii) “reverse cutting” whereby the cutting edge is on the outside; (iv) “trocar point” or “tapercut” whereby the needle body is round and tapered, but ends in a small triangular cutting point; (v) “blunt” points for sewing friable tissues; (vi) “side cutting” or “spatula points” whereby the needle is flat on top and bottom with a cutting edge along the front to one side (these are typically used for eye surgery). Suture needles may also be of several shapes including, (i) straight, (ii) half curved or ski, (iii) ¼ circle, (iv) ⅜ circle, (v) ½ circle, (vi) ⅝ circle, (v) and compound curve. Suturing needles are described, for example, in U.S. Pat. Nos. 6,322,581 and 6,214,030 (Mani, Inc., Japan); and U.S. Pat. No. 5,464,422 (W. L. Gore, Newark, Del.); and U.S. Pat. Nos. 5,941,899; 5,425,746; 5,306,288 and 5,156,615 (US Surgical Corp., Norwalk, Conn.); and U.S. Pat. No. 5,312,422 (Linvatec Corp., Largo, Fla.); and U.S. Pat. No. 7,063,716 (Tyco Healthcare, North Haven, Conn.). Other suturing needles are described, for example, in U.S. Pat. Nos. 6,129,741; 5,897,572; 5,676,675; and 5,693,072. The sutures described herein may be deployed with a variety of needle types (including without limitation curved, straight, long, short, micro, and so forth), needle cutting surfaces (including without limitation, cutting, tapered, and so forth), and needle attachment techniques (including without limitation, drilled end, crimped, and so forth). Moreover, the sutures described herein may themselves include sufficiently rigid and sharp ends so as to dispense with the requirement for deployment needles altogether.
“Suture thread” refers to the filamentary body component of the suture, and, for sutures requiring needle deployment, does not include the suture needle. The suture thread may be monofilamentary, i.e., formed of a single filament, or multifilamentary, i.e., formed from a combination of two or more filaments, e.g., three filaments arranged in a braided fashion. The terms “filament” and “filamentary” are used in their ordinary sense, to refer to a long thin structure, and therefore in many instances herein the suture thread is also identified as the elongated body or elongated suture body, where these terms are interchangeable. The filamentous suture thread has a length that is many times its diameter, and in various embodiments the suture thread has a length that is at least 5 times, or at least 10 times, or at least 20 times, or at least 30 times, or at least 40 times, or at least 50 times the diameter of the thread. Indeed, the length of the suture thread may even be at least 100 times the diameter of the thread. In addition to being filamentous, the suture thread is highly flexible. In other words, the thread will bend in any direction as the surgeon moves the suture through the tissue of the patient. The thread may have some memory of its storage condition, for example, if the thread has been stored for a long period of time in a wound-up circular form, it may tend to return to that form even after it has been released from its storage container and unwound. However, the thread is nevertheless going to follow the needle to which it is attached along any path which the needle makes through and around tissue or a wound. The thread can therefore be described as flexible, or pliable. Stated another way, any two adjacent segments of suture thread may be placed, relative to one another, at any angle from essentially or very near to 0 (where the two segments are folded back upon one another) to 180 degrees (where the two segments follow in tandem along a single straight line). The suture thread has a length, where that length is typically at least 5 inches, or at least 10 inches, or at least 15 inchers, or at least 20 inches. The suture thread will typically have two ends, which may be described as a deployment end and/or a trailing end. In such a case, the deployment end of the suture thread is that end which will first enter tissue, usually being adjacent to a needle, while the trailing end of a suture thread would be that end of the thread which is not the deployment end.
“Tissue elevation procedure” refers to a surgical procedure for repositioning tissue from a lower elevation to a higher elevation (i.e. moving the tissue in a direction opposite to the direction of gravity). The retaining ligaments of the face support facial soft tissue in the normal anatomic position. However, with age, gravitational effects achieve a downward pull on this tissue and the underlying ligaments, and fat descends into the plane between the superficial and deep facial fascia, thus allowing facial tissue to sag. Face-lift procedures are designed to lift these sagging tissues, and are one example of a more general class of medical procedure known as a tissue elevation procedure. More generally, a tissue elevation procedure reverses the appearance change that results from gravitation effects over time, and other temporal effects that cause tissue to sag, such as genetic effects. It should be noted that tissue can also be repositioned without elevation; in some procedures tissues are repositioned laterally (away from the midline), medially (towards the midline) or inferiorly (lowered) in order to restore symmetry (i.e. repositioned such that the left and right sides of the body “match”).
“Tissue retainer”, or simply “retainer”, refers to a suture element having a retainer body projecting from the suture body and a retainer end adapted to penetrate tissue; an example of a tissue retainer is a barb. Each retainer is adapted to resist movement of the suture in a direction other than the direction in which the suture is deployed into the tissue by the clinician, by being oriented substantially to the deployment direction (that is, they lie flat when pulled in the deployment direction, and open or “fan out” when pulled in a direction contrary to the deployment direction). As the tissue-penetrating end of each retainer points away from the deployment direction when moving through tissue during deployment, the tissue retainers should not catch or grab tissue during this phase. Once the self-retaining suture has been deployed, a force exerted in another direction (often substantially opposite to the deployment direction) causes the retainers to be displaced from their deployment positions (that is, yielding toward or resting substantially along the suture body), forces the retainer ends to open (or “fan out”) from the suture body in a manner that catches and penetrates into the surrounding tissue, and results in tissue being caught between the retainer and the suture body, thereby “anchoring” or affixing the self retaining suture in place.
“Unidirectional suture” refers to a suture having a deployment end, a trailing end, and retainers oriented to the deployment end. The trailing end may be used to prevent the suture from moving out of the tissue in the direction of deployment, either by having a knot tied in it or by being provided with an anchoring element that remains outside the point in the tissue into which the deployment end of the suture was initially inserted. (In contrast, a bidirectional suture has retainers oriented in one direction at one end and retainers oriented in the other direction at the other end. A bidirectional suture is typically armed with a needle at each end of the suture thread. The bidirectional suture may have a retainer-free transitional segment located between the two retainer orientations.
“Wound closure” refers to a surgical procedure for closing of a wound. An injury, especially one in which the skin or another external or internal surface is cut, torn, pierced, or otherwise broken is known as a wound. A wound commonly occurs when the integrity of any tissue is compromised (e.g., skin breaks or burns, muscle tears, or bone fractures). A wound may be caused by an act, such as a gunshot, fall, or surgical procedure; by an infectious disease; or by an underlying medical condition. Surgical wound closure facilitates the biological event of healing by joining, or closely approximating, the edges of those wounds where the tissue has been torn, cut, or otherwise separated. Surgical wound closure directly apposes or approximates the tissue layers, which serves to minimize the volume of new tissue formation required to bridge the gap between the two edges of the wound. Closure can serve both functional and aesthetic purposes. These purposes include elimination of dead space by approximating the subcutaneous tissues, minimization of scar formation by careful epidermal alignment, and avoidance of a depressed scar by precise eversion of skin edges.
Unidirectional Self-Retaining Sutures
Self-retaining sutures (including barbed sutures) differ from conventional sutures in that they possess numerous tiny tissue retainers (such as barbs) which anchor into the tissue following deployment and resist movement of the suture in a direction opposite to that in which the retainers face, thereby eliminating the knots that would otherwise have to be tied, around the deployment end of the suture, to affix adjacent tissues together (a “knotless” closure) at the site where the suture deployment end exits from the tissue. By eliminating knot tying, associated complications are eliminated, including, but not limited to (i) spitting (a condition where the suture, usually a knot) pushes through the skin after a subcutaneous closure), (ii) infection (bacteria are often able to attach and grow in the spaces created by a knot), (iii) bulk/mass (a significant amount of suture material left in a wound is the portion that comprises the knot), (iv) slippage (knots can slip or come untied), and (v) irritation (knots serve as a bulk “foreign body” in a wound). Suture loops in the tissue that are created by knots tied during a surgical procedure may lead to ischemia (they create tension points that can strangulate tissue and limit blood flow to the region) and increased risk of dehiscence or rupture at the surgical wound. Knot tying is also labor intensive and can comprise a significant percentage of the time spent closing a surgical wound. Additional operative procedure time is not only bad for the patient (complication rates rise with time spent under anesthesia), but it also adds to the overall cost of the operation (many surgical procedures are estimated to cost between $15 and $30 per minute of operating time). Thus, knotless sutures not only allow patients to experience an improved clinical outcome, but they also save time and costs associated with extended surgeries and follow-up treatments.
Self-retaining sutures for wound closure also result in better approximation of the wound edges, evenly distribute the tension along the length of the wound (reducing areas of tension that can break or lead to ischemia), decrease the bulk of suture material remaining in the wound (by eliminating knots tied during procedures) and reduce spitting (the extrusion of suture material—typically knots—through the surface of the skin. All of these features are thought to reduce scarring, improve cosmesis, and increase wound strength relative to wound closures effected with plain sutures or staples.
Self-retaining sutures also lend themselves to a variety of specialized indications; for example, they are suitable for tissue elevation procedures where tissue is moved from its previous location and repositioned into a new anatomical location (this is typically performed in cosmetic procedures where “drooping” tissue is elevated and fixed in a more “youthful” position; or where “out-of-position” tissue is moved back to its correct anatomical location). Such procedures include facelifts, brow lifts, breast lifts, buttocks lifts, and so forth.
Unidirectional self-retaining sutures and their uses have been described in various publications mentioned above. While the segment of suture thread adjacent to the deployment end of a unidirectional self-retaining suture is provided with tissue retainers for preventing slippage of the suture in a direction substantially opposite the direction of deployment, the trailing end may be provided with an anchor to prevent slippage in the deployment direction (and in order to avoid the undesirable potential effects of requiring a knot to be tied during a surgical procedure in the trailing end of a unidirectional suture). Various unidirectional sutures with anchors, included anchors having loop elements, have been described in, for example, U.S. Patent Application Publication Nos. 20050267531, 20040060410, issued as U.S. Pat. No. 8,795,332 on Aug. 5, 2014, 20080255611, issued as U.S. Pat. No. 8,915,943 on Dec. 23, 2014, and 20100063540, issued as U.S. Pat. No. 10,016,196 on Jul. 10, 2018.
Several problems common to existing unidirectional self-retaining sutures having loop anchors can be addressed by the embodiments of this invention. For example, unidirectional sutures featuring fixed loop anchors, such as those described in some of the aforementioned publications, have several disadvantages, the first of which is that the size of the fixed loop should typically be fairly small (that is, not much bigger than the size of the first stitch that the clinician would wish to make with it), which requires the clinician to make some effort (and therefore expend some valuable surgical time) in finding the loop and running the deployment end of the suture through it. Because the suture of the present invention includes a variable loop anchor, the clinician is presented with a large loop through which he or she can easily pass the deployment end of the suture; this is of particular benefit in laparoscopic procedures. Then, when such a suture is pulled through tissue, if the first stitch taken is larger than the longest interior dimension of the fixed loop after the suture body has been drawn through it and tensioned, then the base of the loop (that is, where the loop joins the suture body) can be pulled into the tissue, resulting in potential issues such as those described above in connection with knot-tying. On the other hand, if the first stitch taken is smaller than the longest interior dimension of the fixed loop after the suture body has been drawn through it and tensioned, then excess loop material remains at the tissue site, an axiomatically undesirable condition which could also cause surgical instruments to get caught on the excess material during the procedure. In the case of the present invention, the adjustable nature of the variable loop anchor allows the clinician to avoid these difficulties.
In addition, there are physical issues of loop integrity associated with a fixed loop anchor. For example, issues of fixed loop attachment are avoided by the variable loop suture of the present invention. Where the loop of a fixed loop suture is welded or otherwise attached to the suture body, either as a separate structure joined at its base to the suture or as an end of the suture turned back onto and attached to the suture to create a looped portion, the base of the loop (where it joins the suture body) is the attachment region and is also where the suture is pulled into the tissue. As such, it is subject to tissue drag and the potential for breakage or peeling at the attachment region. While this may be dealt with by increasing the length of the attachment region and/or providing a taper or chamfer, it is avoided entirely by sutures of the present invention as the eyelet of the variable loop will sit superficial to the tissue being approximated, will not need to pass into the tissue, and is not subject to tissue drag. In addition, for sutures of the present invention, the main load when tensioning the tissue is taken by the variable loop as opposed to the eyelet. As a result, the eyelet does not hold the primary tension when seating the first stitch, and the weld length can be shortened thereby reducing local biomaterial effects (inflammation and/or risk of infection) on wound healing.
Unidirectional self-retaining sutures of the present invention are provided with a variable length loop configuration at one end and a deployment end at the other. Wound closure is achieved by starting at one end of the wound containing tissue to be approximated, passing the deployment end through both edges of the tissue, pulling the end of the suture containing the needle through the tissue until the loop segment is near the first edge of tissue, and passing the end with the needle back through the variable loop portion of the device. Tension is pulled until the loop seats on the tissue and the desired hold is achieved. The deployment end is now passed repeatedly through the tissue in a pattern determined by the clinician to best facilitate wound closure starting at the end just seated moving in one direction toward the other terminus of the tissue to be approximated. A “J stitch” can used to complete the process and the needle is removed akin to the procedure used with bi-directional configurations.
Turning now to
Continuing with
As shown in
As shown in
As can be seen in
As illustrated by comparison of
In one embodiment, the invention provides a self-retaining system comprising a self-retaining suture as described herein including a deployment means. The self-retaining suture comprises a suture thread with a plurality of tissue retainers and one or more (usually only one is necessary) eyelets. The eyelet may be formed into a circular or generally circular shape, and in this shape the diameter of the eyelet can be measured in the usual way as the distance between any two opposing points (two points on opposite sides of the circle) on the inside of the eyelet. The needle diameter may be selected in view of the eyelet diameter. For example, the needle diameter may be larger than the eyelet diameter, for example, the needle diameter may be at least 5% greater, or at least 10% greater, or at least 15% greater or at least 20% greater than the eyelet diameter. In this example, a fixed loop is formed when the deployment end of the suture body passes through the eyelet and then the deployment end of the suture is attached to a suture needle. Since the suture needle has a diameter that is greater than the eyelet diameter, the deployment end of the suture cannot be taken back through the eyelet without breaking the eyelet and/or the needle, unless the eyelet is made of a flexible material which can stretch. The suture body of the invention typically does not stretch to any appreciable extent. Thus, the loop may be seen as being a fixed loop. In another example, the needle diameter is approximately the same as the eyelet diameter, in other words, the needle diameter is plus/minus 5% of the eyelet diameter, or in another embodiment, plus/minus 10% of the eyelet diameter. In this case, the needle diameter and the eyelet diameter are approximately the same, and it will be difficult or impossible to pull the deployment end of the suture back through the eyelet, after the deployment end has been attached to a needle. In another example, the needle diameter is chosen to be less than the eyelet diameter, such as where the needle diameter is less than 90% of the eyelet diameter, or less than 80%, or less than 70% or less than 60% or less than 50% of the eyelet diameter. In this case, the deployment end may be attached to a needle, and then the needle may be threaded through the eyelet. This option provides greater flexibility in forming the variable looped suture.
The needle diameter is typically chosen to be at least the same as the suture diameter, and in various embodiments the needle diameter is at least 110%, or at least 120%, or at least 130%, or at least 140%, or at least 150% of the suture thread diameter.
Use of self-retaining variable loop sutures of the present invention is illustrated in
In one embodiment, the invention provides a method of suturing, where this method comprises: (a) providing a self-retaining system comprising a suture needle attached at an end of a self-retaining suture, the self-retaining suture comprising a suture thread having a thread diameter, a plurality of tissue retainers and an eyelet, where the suture thread passes through the eyelet to form a variable loop having an original diameter; (b) inserting the needle into the tissue of a patient at a first tissue location; (c) withdrawing the needle from the tissue of the patient at a second tissue location; (d) passing the needle and at least some of the suture thread through the variable loop; and (e) inserting the needle into the tissue of the patient at a third tissue location. Optionally, one or more of the following statements may be used in combination with a statement providing a method of suturing as provided herein: the suture thread is passed through the variable loop while simultaneously the diameter of the variable loop is decreased where optionally the decrease is greater than 50% of the original variable loop diameter; the diameter of the variable loop is decreased to provide a variable loop diameter that is less than 10 times the thread diameter; the diameter of the variable loop is decreased until the variable loop fits snugly around the suture thread; the suture thread is passed through the variable loop until the eyelet, the variable loop and the suture body together form an anchor on the tissue, and where further movement of the suture thread in the direction of the suture needle is resisted by the anchor.
In another embodiment, the invention provides a method of suturing tissue, the method comprising: (a) providing a suture thread attached to a suture needle, a portion of the suture thread forming a loop having an adjustable circumference; (b) threading the needle through the loop; and (c) deploying the needle through tissue of a patient and approximating the tissue with the suture thread. Optionally, one or more of the following statements may be used in combination with a statement providing a method of suturing as provided herein: the loop comprises suture thread and a fixed loop (also referred to as an eyelet), the fixed loop having an opening through which the suture thread passes to thereby form the loop having an adjustable circumference; the fixed loop (also referred to herein as the eyelet) and any means by which the fixed loop is formed or attached to the suture thread, all lie on a surface of the tissue after the tissue has been completely approximated; the circumference of the variable loop is adjusted to a desired value prior to threading the deployment end or needle through the variable loop; the circumference of the variable loop is adjusted to a desired value after threading the deployment end or needle through the variable loop; the circumference of the loop is adjusted to a desired value in the range, where that desired range may be 0.5 to 3 inches or 0.5 to 2 inches, or 0.5 to 1 inch, depending on the custom of the clinician and the nature of the wound that is being sewn; the circumference of the loop is reduced to a desired value, i.e., a value desired by the clinician as appropriate for his or her comfort and the wound being sewn; the needle is passed into and then out of tissue at first and second locations, respectively, prior to being threaded through the variable loop; the suture thread comprises tissue retainers; the suture thread comprises cuts in the suture thread, the cuts forming the tissue retainers, in other words, the cut provides a separation between suture thread material on either side of the cut, where the portion of suture thread material nearer the periphery of the suture thread may be pulled up and away from the suture thread on the other side of the cut, to thereby form a structure which is a tissue retainer; a cut made in the suture thread lies in a single plane, or in two planes such as where the angle of the cut is changed during the process of forming the cut in the suture thread, e.g., the first cut into the suture is relatively deep while the cut after the first cut is not (or not very) deep; a cut is made into the suture thread so as to provide a barb; tissue retainers are present on that portion of the suture thread that forms the loop having an adjustable circumference; tissue retainers are absent from a portion of the loop having an adjustable circumference.
In another embodiment, the invention provide a method of suturing that includes forming an anchor at a location on tissue of a patient, the method comprising: (a) providing a suture thread with an eyelet, the suture thread attached to a suture needle at a deployment end of the suture thread; (b) deploying the suture needle into tissue at the location, and then withdrawing the suture needle from tissue at an exit point; (c) passing the needle through a loop comprising suture thread, the loop having a variable circumference; (d) applying tension to the suture thread by pulling on the deployment end of the suture thread; (e) to thereby provide an anchor on top of the tissue, the anchor comprising the eyelet, the loop and a portion of the suture thread, the anchor resisting movement of the suture thread in the direction of the deployment end of the suture thread. Optionally, one or more of the following statements may be used in combination with a statement providing a method of suturing as provided herein: the loop comprises suture thread and a fixed loop (also referred to as an eyelet), the fixed loop having an opening through which the suture thread passes to thereby form the loop having an adjustable circumference; the fixed loop (also referred to herein as the eyelet) and any means by which the fixed loop is formed or attached to the suture thread, all lie on a surface of the tissue after the tissue has been completely approximated; the circumference of the variable loop is adjusted to a desired value prior to threading the deployment end or needle through the variable loop; the circumference of the variable loop is adjusted to a desired value after threading the deployment end or needle through the variable loop; the circumference of the loop is adjusted to a desired value in the range, where that desired range may be 0.5 to 3 inches or 0.5 to 2 inches, or 0.5 to 1 inch, or at least 0.5 inches, or at least 1 inch, or at least 1.5 inches, depending on the custom of the clinician and the nature of the wound that is being sewn; the circumference of the loop is reduced to a desired value, i.e., a value desired by the clinician as appropriate for his or her comfort and the wound being sewn; the needle is passed into and then out of tissue at first and second locations, respectively, prior to being threaded through the variable loop; the suture thread comprises tissue retainers; the suture thread comprises cuts in the suture thread, the cuts forming the tissue retainers, in other words, the cut provides a separation between suture thread material on either side of the cut, where the portion of suture thread material nearer the periphery of the suture thread may be pulled up and away from the suture thread on the other side of the cut, to thereby form a structure which is a tissue retainer; a cut made in the suture thread lies in a single plane, or in two planes such as where the angle of the cut is changed during the process of forming the cut in the suture thread, e.g., the first cut into the suture is relatively deep while the cut after the first cut is not (or not very) deep; a cut is made into the suture thread so as to provide a barb; tissue retainers are present on that portion of the suture thread that forms the loop having an adjustable circumference; tissue retainers are absent from a portion of the loop having an adjustable circumference.
To serve the purpose of allowing a clinician to identify and differentiate the eyelet, a market may be placed in the vicinity of the eyelet. The marker should be readily recognized and distinguished by the physician under the conditions in which the suture is to be used. For example, in microsurgery applications, markers may be used that are visible under the microscope, but not necessarily visible to the naked eye. Likewise in endoscopic applications, markers should used be that are visible through the endoscope and associated display system. If the suture will be used with fluoroscopic visualization then the markers may include radiopaque markers. If the suture will be used with ultrasound visualization then the markers may include echogenic markers. Thus, different markers and different types of markers may be appropriate under different circumstances depending upon the circumstances of the procedure and the scanning/imaging/visualization technology utilized in the procedure.
Markers can include different colors such as red, green, orange, yellow, green, blue etc. In some cases it may be desirable to use a color for markers that is uncommon in the operative environment. For example, it may be desirable to use green markers because green is not common in the human body. In endoscopic applications using green is advantageous because the video system can be programmed to emphasize green and enhance marker visualization without interfering with the remainder of the image.
The markers can be formed by various conventional methods. For example, the markers can be coated, sprayed, glued, dyed, stained, or otherwise affixed to the self-retaining suture systems or components thereof. Traditional colourant application processes include, without limitation, dipping, spraying (by, for example, an ink jet), painting, printing, applying and/or coating colourants on the suture section of interest. Critical fluid extraction (such as carbon oxide) may also be used to add colourant locally to all or part of the section desired to be marked. Alternatively, colourant(s) for the suture section of interest may be included in a portion of the suture material that is used to form the suture body, wherein that portion is in the section of interest of the manufactured suture.
Additionally, the suture section of interest can be demarcated by using an energy-activated colourant. For example, when a laser-activated colourant (that is, a pigment or dye which permanently changes colour after being exposed to laser energy) is used to colour the suture, then the eyelet or other suture section of interest can be demarcated by using laser energy to permanently change the suture coating in the suture section of interest. This also applies to using other energy activated colourants which are activated by other energy sources such as, but not limited to, heat, chemicals, microwaves, ultraviolet light, or x-rays. For example, bleaching chemicals such as sodium hypochlorite or hydrogen peroxide will permanently change the colourant's colour which allows for the demarcation of the eyelet or other region of the suture.
Additionally, the colourant(s) employed for demarcating the suture section of interest may be included on a plastic biocompatible material which is applied on the suture at the section of interest. Such a layer may be absorbable, such as a polyglycolide coating which has a colourant to mark the suture section of interest, or it may be a non-absorbable material, such silicone. The coloured material may be synthetic or may be derived from a natural source (whether the material be modified or unmodified), such as collagen. The plastic biocompatible material may be applied to the suture before or after the retainers are formed on the suture body.
Alternatively, the eyelet or other suture region may be reverse-marked, such that where the suture body is already visibly coloured, the colourant may be absent from all or part of the suture section of interest such that at least a portion of the section of interest is optically distinguishable by the surgeon from the rest of the suture. Such a suture may manufactured by including a colourant-free portion of suture material in the suture section of interest area during the manufacture of the suture body (for example, by extrusion) or by removal of colourant from the suture section of interest after the suture body has been manufactured, whether before or after retainers have been formed on the suture body. Colourant may be removed locally by, for example, critical fluid extraction such as (e.g., carbon oxide). It is not necessary to remove all of the colourant from the section of interest of the suture as long as there is a difference detectible by a surgeon between the section of interest and the rest of the suture.
Another example of a reverse-marked suture is one that lacks a coloured layer that is present on the rest of the suture body. A plastic biocompatible material bearing a colourant may be applied on the other sections of the suture, and at least where the other sections border the section of interest. Examples of such materials are discussed above. As in the foregoing examples, demarcating the suture section of interest may be effected in the suture manufacturing process either before or after forming retainers.
Another example of a reverse-marked suture is one having a coaxial structure wherein each coaxial layer having a different colour, and a portion of the outermost layer(s) is removed to visually expose a layer below. For example, a dual-layer monofilament polypropylene suture can be produced with a white inner core (intercoaxial layer) with a blue outer coaxial layer, and portions of the outer layer can be removed to visually expose the white inner monofilament to mark the suture section of interest.
Yet another example of a reverse-marked suture is one in which an external coating is removed (or partially removed) from the suture in the suture section of interest, and where either the coating or base suture has a contrasting colour difference. This technique of removing (or partially removing) material in the suture section of interest may also create a tactile demarcation of the suture section of interest.
The marking may include a radio-detectable compound or magnetic resonance imaging detectable compound. For example the suture section of interest provided with barium sulfate (BaSO4), such as by impregnating the suture with barium sulfate or adding a coating containing barium sulfate, will be detectable by electromagnetic energy. In the case of x-ray detection, the barium sulfate marked section of interest would be radiopaque. Likewise, computed tomography (CT) scans or computed axial tomography (CAT) scans can be used to detect the radio detectable section of interest. The use of electromagnetic energy for radio detection of the transition section is not limited to using x-ray wavelengths as other radio frequencies may be used. Likewise, gadolinium (Gd) or gadolinium compounds can be used for the marking of the suture section of interest especially when the detection will be done by using magnetic resonance imaging (MRI). The use of radio detectable or magnetic resonance imaging detectable marking may be useful to the surgeon during laparoscopic surgical procedures.
The region of the variable loop at the base of the eyelet may be marked to increase its visibility to the clinician, either for the purpose of indicating where it is during suture deployment, or to allow the clinician to identify where the anchor is in order to sever it for the purpose of removing the deployed suture from the tissue.
In some embodiments, the suture may additionally be provided with a surface feature for some portion of the suture body adjacent to the fixed loop, in order to provide some resistance, perceptible to the clinician, to the variable loop being pulled all the way to the fixed loop. While in some of these embodiments it is not necessary for the surface feature to prevent the variable loop from being tightened all the way to the fixed loop, in yet other embodiments the surface feature may function to do just that. Some examples, without limitation, of suitable surface features are dimpling, rippling, corrugation, roughening, serrations, ridges, filaments, so forth. In this connection,
In
Referring now to
Referring now to
The grasp engagement element can be made from either or both absorbable or non-absorbable materials. For example, a non-absorbable grasp engagement element made from polyester felt or polytetrafluoroethylene felt can be used to allow the surgeon to find and gently pull the eyelet to facilitate removal of the anchor from the suture body if and when it is desired to remove the suture from tissue (by detaching the anchor and then pulling the suture out from its deployment end). Examples of absorbable materials include glycolide and glycolide-lactide polymers. The use of an absorbable grasp engagement element can be especially useful for deep cavity tissue closures where the surgeon may wish to have a choice of whether or not to leave the grasp engagement element inside the body. Additionally, the grasp engagement element can be coloured (as shown by the shading of tab 636 of
Manufacturing and Materials
Suture threads described herein may be produced by any suitable method, including without limitation injection moulding, stamping, cutting, laser, extrusion, and so forth. With respect to cutting, polymeric thread or filaments may be manufactured or purchased for the suture body, and the retainers can be subsequently cut onto or into the suture body; they may be hand-cut, laser-cut, or mechanically machine-cut using blades, cutting wheels, grinding wheels, and so forth. The sutures may be made of any suitable biocompatible material, and may be further treated with any suitable biocompatible material, whether to enhance the sutures' strength, resilience, longevity, or other qualities, or to equip the sutures to fulfill additional functions besides joining tissues together, repositioning tissues, or attaching foreign elements to tissues. As are appropriate to the indication or use of the suture in question, the sutures may be provided with retainers of various configurations, arrangements, densities, and so forth, such as those taught in publications referenced herein.
Variable loops for sutures of the present invention may be formed in several ways. Referring to the suture 700 shown in
Noteworthy is that the non-deployment end of the suture thread need not have any particular shape or appearance or function when it is located in the attachment region. Since neither the eyelet nor the adjacent attachment region of the variable loop sutures of the present invention are intended to enter tissue, there is no need to facilitate the entry of, e.g., the attachment region by providing any particular shape that would facilitate such entry. For example, the end or tip of the non-deployment end of the sutures of the present invention may be squared off compared to the sides of the adjacent suture thread, rather than having an angle or slant that would facilitate entry into tissue. The deployment end may, in fact, be designed or adapted to retard entry of the attachment region into tissue. This is particularly relevant when the eyelet is formed by having the attachment region located adjacent to the eyelet. This same issue is not relevant if the attachment region is part of the material that forms the eyelet.
Alternatively, the eyelet 912 may be integral to the suture body 902 as is shown by the suture 900 illustrated in
As a further alternative embodiment, the eyelet may be formed independently from the suture thread, and then the eyelet is joined to the suture thread at a suitable location. For example, the non-deployment end of the suture thread may be tied to an eyelet, in the same manner as the end of a rope can be tied to a ring. In this alternative embodiment, it is desirable that the joining together of the suture thread and the eyelet be done in a secure manner, so that the eyelet does not become separated from the suture thread at an inopportune time. A secure joining of the eyelet and the suture thread may be accomplished, for example, by welding the knot which is used to tie the eyelet to the suture thread. As another example, the eyelet may take the form of a ring (or polygon or other suitable shape defining a hole through which the suture thread may pass or be threaded) where the ring has a hole through which the suture thread may pass in order to secure the ring to the suture thread. For instance, after passing through this hole, the non-deployment end of the suture thread may be formed into a knot of such a size that it cannot easily pass through the hole. In this way, the suture thread is secured to an eyelet. As a final example, the eyelet may be securely joined to a feature where the feature is readily secured to the suture thread. For instance, two rings joined in the shape of a
The dimensions of the eyelet may be varied; for example, the inner transverse length of the eyelet (that is, the longest inner dimension across the eyelet) may be as small as about the transverse length of the suture body cross section (that is, the longest dimension across the suture body cross section, regardless of the shape of the cross section) and as large as about four times or even ten times the transverse length of the suture body cross section. Other ranges for the inner transverse length that may be suitable are one-and-a-half times the transverse length of the suture cross section to about ten times transverse length of the suture cross section, one-and-a-half times the transverse length of the suture cross section to about four times transverse length of the suture cross section, or about twice the transverse length of the suture cross section to about three times the transverse length of the suture cross section.
After preparation, the self-retaining suture system may be packaged for ease of storage, handling and use. Suitable packaging systems are known in the art, where exemplary suture packages are described in U.S. Patent Publication Nos. 20110056859, issued as U.S. Pat. No. 8,459,446 on Jun. 11, 2013 and 20100230300, now abandoned. Before, but preferably after the packaging process, the suture may be sterilized by, e.g., radiation.
In one embodiment there is provided a method of making a self-retaining suture system, the method comprising (a) providing a suture thread, the suture thread comprising a deployment end and either comprising or being attached to an eyelet, (b) forming a plurality of cuts in the suture thread to provide a plurality of tissue retainers; (c) threading the deployment end of the suture thread through the eyelet to thereby form a loop of variable circumference; (d) threading the deployment end of the suture through the loop of variable circumference to provide a suture ready for packaging; (e) placing the suture ready for packaging into a package suitable for storing the suture and suitable for allowing a health care worker to readily access the suture ready for packaging. One or more of the following statements may be used in combination with the description of a method of making a self-retaining suture system, to further describe and state the invention: the method further comprises attaching a suture needle to an end of the suture thread, where optionally the needle is attached to the suture thread after the end of the suture thread has been threaded through the eyelet or the needle is attached to the suture thread after the end of the suture thread has been threaded through the loop of variable circumference; the suture thread is sterilized; the eyelet is integrally formed with the suture thread; the eyelet is attached to the suture thread; the eyelet is formed by (a) folding a non-deployment end of the suture thread, also referred to as the trailing end of the suture thread, back upon a portion of the suture thread to provide for an attachment region, wherein the non-deployment end of the suture is in contact with the portion of the suture thread in the attachment region; and (b) adhering the non-deployment end and the portion of the suture thread in the attachment region to one another, where in such a case, the adhering may be achieved by welding together the non-deployment end and the portion of the suture thread in the attachment region or it may be achieved by gluing together the non-deployment end and the portion of the suture thread in the attachment region; the eyelet comprises the attachment region which will occur in the case where the deployment end is folded back onto a portion of the suture thread that forms part of the eyelet; the eyelet is adjacent to the attachment region which will occur in the case where the deployment end is folded back onto a portion of the suture thread that does not form part of the eyelet but which is adjacent to the eyelet at the base of the eyelet.
Self-retaining sutures described herein may also incorporate materials that further promote tissue engagement. In addition to tissue engagement at the retainers, use of tissue engagement-promoting materials in at least part of the suture bodies (whether or not such materials also make up all or part of the retainers) can enhance the ability of the sutures to stay in place. One such class of tissue engagement-promoting materials are porous polymers that can be extruded to form suture bodies, including both microporous polymers and polymers that can be extruded with bubbles (whether bioabsorbable or nonbioabsorbable). A suture synthesized with such materials can have a three-dimensional lattice structure that increases tissue engagement surface area and permits tissue infiltration into the suture body itself, thus having a primary structure that promotes successful suture use. Moreover, by optimizing pore size, fibroblast ingrowth can be encouraged, further facilitating the suture to be anchored in the tissue.
One such microporous polymer is ePTFE (expanded polytetra-fluoroethylene). Self-retaining incorporating ePTFE (and related microporous materials) are well-suited to uses requiring a strong and permanent lift (such as breast lifts, face lifts, and other tissue repositioning procedures), as tissue infiltration of the suture results in improved fixation and engraftment of the suture and the surrounding tissue thus providing superior hold and greater longevity of the lift.
Additionally, self-retaining sutures described herein may be provided with compositions to promote healing and prevent undesirable effects such as scar formation, infection, pain, and so forth. This can be accomplished in a variety of manners, including for example: (a) by directly affixing to the suture a formulation (e.g., by either spraying the suture with a polymer/drug film, or by dipping the suture into a polymer/drug solution), (b) by coating the suture with a substance such as a hydrogel which will in turn absorb the composition, (c) by interweaving formulation-coated thread (or the polymer itself formed into a thread) into the suture structure in the case of multi-filamentary sutures, (d) by inserting the suture into a sleeve or mesh which is comprised of, or coated with, a formulation, or (e) constructing the suture itself with a composition. Such compositions may include without limitation anti-proliferative agents, anti-angiogenic agents, anti-infective agents, fibrosis-inducing agents, anti-scarring agents, lubricious agents, echogenic agents, anti-inflammatory agents, cell cycle inhibitors, analgesics, and anti-microtubule agents. For example, a composition can be applied to the suture before the retainers are formed, so that when the retainers engage, the engaging surface is substantially free of the coating. In this way, tissue being sutured contacts a coated surface of the suture as the suture is introduced, but when the retainer engages, a non-coated surface of the retainer contacts the tissue. Alternatively, the suture may be coated after or during formation of retainers on the suture if, for example, a fully-coated rather than selectively-coated suture is desired. In yet another alternative, a suture may be selectively coated either during or after formation of retainers by exposing only selected portions of the suture to the coating. The particular purpose to which the suture is to be put or the composition may determine whether a fully-coated or selectively-coated suture is appropriate; for example, with lubricious coatings, it may be desirable to selectively coat the suture, leaving, for instance, the tissue-engaging surfaces of the sutures uncoated in order to prevent the tissue engagement function of those surfaces from being impaired. On the other hand, coatings such as those comprising such compounds as anti-infective agents may suitably be applied to the entire suture, while coatings such as those comprising fibrosing agents may suitably be applied to all or part of the suture (such as the tissue-engaging surfaces). The purpose of the suture may also determine the sort of coating that is applied to the suture; for example, self-retaining sutures having anti-proliferative coatings may be used in closing tumour excision sites, while self-retaining sutures with fibrosing coatings may be used in tissue repositioning procedures and those having anti-scarring coatings may be used for wound closure on the skin. As well, the structure of the suture may influence the choice and extent of coating; for example, sutures having an expanded segment may include a fibrosis-inducing composition on the expanded segment to further secure the segment in position in the tissue. Coatings may also include a plurality of compositions either together or on different portions of the suture, where the multiple compositions can be selected either for different purposes (such as combinations of analgesics, anti-infective and anti-scarring agents) or for their synergistic effects.
Clinical Uses
In addition to the general wound closure and soft tissue repair applications described in the preceding sections, self retaining sutures can be used in a variety of other indications.
Self-retaining sutures described herein may be used in various dental procedures, i.e., oral and maxillofacial surgical procedures. The above-mentioned procedures include, but are not limited to, oral surgery (e.g., removal of impacted or broken teeth), surgery to provide bone augmentation, surgery to repair dentofacial deformities, repair following trauma (e.g., facial bone fractures and injuries), surgical treatment of odontogenic and non-odontogenic tumors, reconstructive surgeries, repair of cleft lip or cleft palate, congenital craniofacial deformities, and esthetic facial surgery. Self-retaining dental sutures may be degradable or non-degradable, and may typically range in size from USP 2-0 to USP 6-0.
Self-retaining sutures described herein may also be used in tissue repositioning surgical procedures. Such surgical procedures include, without limitation, face lifts, neck lifts, brow lifts, thigh lifts, and breast lifts. Self-retaining sutures used in tissue repositioning procedures may vary depending on the tissue being repositioned; for example, sutures with larger and further spaced-apart retainers may be suitably employed with relatively soft tissues such as fatty tissues.
Self-retaining sutures described herein may also be used in microsurgical procedures that are performed under a surgical microscope (and thus may be referred to as “self-retaining microsutures”). Such surgical procedures include, but are not limited to, reattachment and repair of peripheral nerves, spinal microsurgery, microsurgery of the hand, various plastic microsurgical procedures (e.g., facial reconstruction), microsurgery of the male or female reproductive systems, and various types of reconstructive microsurgery. Microsurgical reconstruction is used for complex reconstructive surgery problems when other options such as primary closure, healing by secondary intention, skin grafting, local flap transfer, and distant flap transfer are not adequate. Self-retaining microsutures have a very small caliber, often as small as USP 9-0 or USP 10-0, and may have an attached needle of corresponding size. They may be degradable or non-degradable.
Self-retaining sutures as described herein may be used in similarly small caliber ranges for ophthalmic surgical procedures and thus may be referred to as “ophthalmic self-retaining sutures”. Such procedures include but are not limited to keratoplasty, cataract, and vitreous retinal microsurgical procedures. Ophthalmic self-retaining sutures may be degradable or non-degradable, and have an attached needle of correspondingly-small caliber.
Self retaining sutures can be used in a variety of veterinary applications for a wide number of surgical and traumatic purposes in animal health.
Although the present invention has been shown and described in detail with regard to only a few exemplary embodiments of the invention, it should be understood by those skilled in the art that it is not intended to limit the invention to the specific embodiments disclosed. Various modifications, omissions, and additions may be made to the disclosed embodiments without materially departing from the novel teachings and advantages of the invention, particularly in light of the foregoing teachings. Accordingly, it is intended to cover all such modifications, omissions, additions, and equivalents as may be included within the spirit and scope of the invention as defined by the following claims. Some specific embodiments of the invention are:
A self-retaining suture comprising: a first end for penetrating tissue; an elongated suture body (which may alternatively be referred to as a suture thread), having a periphery; a first plurality of retainers on the periphery of the elongated body (which may alternatively be referred to as a suture thread or suture body) and oriented to the first end, the first plurality of retainers yielding toward the suture body during movement of the suture through tissue in a direction of deployment of the first end, and resisting movement of the suture, when in tissue, in a direction substantially opposite the direction of deployment of the first end; a second end having a variable loop of variable circumference, wherein the variable loop includes a fixed loop (which may alternatively be referred to as an eyelet) slidably engaging the elongated body for slidingly varying the circumference of the variable loop, and wherein the first end may pass through the variable loop to secure tissue as an anchor, the anchor preventing movement of the suture in the direction of deployment of the first end. Optionally, one or more of the following statements may be used to further describe a self-retaining suture provided herein: the first end is adapted to penetrate tissue; the first end is attached to a needle; the suture further comprises a surface feature on at least some of the periphery of the elongated body between the fixed loop (eyelet) and the first plurality of retainers, the surface feature resisting sliding of the fixed loop over the surface feature, where optionally the surface feature comprises a second plurality of retainers, the second plurality of retainers being oriented away from the first end and/or the surface feature is disposed at least in part in the circumference of the variable loop; the elongated body has a cross section having a transverse length (tl) and the fixed loop has an inner transverse length (TL) and wherein the ratio of TL:tl is about 1:1 to about 10:1 or the ratio of TL:tl is about 1:1 to about 4:1 or the ratio of TL:tl is about 1:1 to about 3:1 or the ratio of TL:tl is about 1.5:1 to about 10:1 or the ratio of TL:tl is about 1.5:1 to about 4:1 or the ratio of TL:tl is about 2:1 to about 3:1; the fixed loop is attached to or further comprises a grasp engagement element; at least one of the retainers of the first plurality differs in configuration from other retainers of the first plurality; retainers of the second plurality differ in configuration from retainers of the first plurality; the fixed loop further comprises a visible marking; the cross section of the elongated suture body (alternatively called suture thread) is non-circular; the cross section of the elongated suture body is polygonal; the suture thread further comprises a therapeutic agent.
A self-retaining suture comprising: a first end for penetrating tissue; an elongated suture body (alternatively called a suture thread) having a periphery and a cross section, the cross section having a transverse length (tl); a first plurality of retainers on the periphery of the elongated body (alternatively called the elongated suture body or suture thread) and oriented to the first end, the first plurality of retainers yielding toward the suture body (alternatively called a suture thread) during movement of the suture through tissue in a direction of deployment of the first end, and resisting movement of the suture, when in tissue, in a direction substantially opposite the direction of deployment of the first end; a second end having a variable loop of variable circumference, wherein the variable loop includes a fixed loop (alternatively identified as an eyelet) slidably engaging the elongated body for slidingly varying the circumference of the variable loop, and wherein the first end may pass through the variable loop to secure tissue as a third, anchoring loop in tissue for preventing movement of the suture in the direction of deployment of the first end.
A self-retaining suture comprising: a first end for penetrating tissue; an elongated suture body having a periphery and a cross section, the cross section having a transverse length (tl); a first plurality of retainers on the periphery of the elongated body and oriented to the first end, the first plurality of retainers yielding toward the suture body during movement of the suture through tissue in a direction of deployment of the first end, and resisting movement of the suture, when in tissue, in a direction substantially opposite the direction of deployment of the first end; a second end having a slip knot, the slip knot comprising a loop of variable circumference through which the first end may pass to secure tissue as an anchor for preventing movement of the suture in the direction of deployment of the first end.
A self-retaining suture comprising: a first end for penetrating tissue; an elongated suture body having a periphery and a cross section, the cross section having a transverse length (tl); a first plurality of retainers on the periphery of the elongated body and oriented to the first end, the first plurality of retainers yielding toward the suture body during movement of the suture through tissue in a direction of deployment of the first end, and resisting movement of the suture, when in tissue, in a direction substantially opposite the direction of deployment of the first end; a second end having a slip knot, the slip knot comprising a loop of variable circumference through which the first end may pass to secure tissue as an anchoring loop in tissue for preventing movement of the suture in the direction of deployment of the first end.
A self-retaining suture comprising: a first end for penetrating tissue; an elongated suture body having a periphery and a cross section, the cross section having a transverse length (tl); a first plurality of retainers on the periphery of the elongated body and oriented to the first end, the first plurality of retainers yielding toward the suture body during movement of the suture through tissue in a direction of deployment of the first end, and resisting movement of the suture, when in tissue, in a direction substantially opposite the direction of deployment of the first end; a second end having a variable loop of variable circumference, wherein the variable loop includes a fixed loop having an inner transverse length (TL) and slidably engaging the elongated body for slidingly varying the circumference of the variable loop, wherein the ratio of TL:tl is about 1:1 to about 10:1; wherein the first end may pass through the variable loop to secure tissue as an anchor for preventing movement of the suture in the direction of deployment of the first end.
This application claims the benefit under 35 U.S.C. § 119(e) of U.S. Provisional Patent Application No. 61/466,924, filed Mar. 23, 2011, which application is hereby incorporated by reference in its entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 709392 | Brown | Sep 1902 | A |
| 733723 | Lukens | Jul 1903 | A |
| 816026 | Meier | Mar 1906 | A |
| 879758 | Foster | Feb 1908 | A |
| 1142510 | Engle | Jun 1915 | A |
| 1248825 | Dederer | Dec 1917 | A |
| 1321011 | Cottes | Nov 1919 | A |
| 1558037 | Morton | Oct 1925 | A |
| 1728316 | Von Wachenfeldt | Sep 1929 | A |
| 1886721 | O'Brien | Nov 1932 | A |
| 2094578 | Blumenthal et al. | Oct 1937 | A |
| 2201610 | Dawson, Jr. | May 1940 | A |
| 2232142 | Schumann | Feb 1941 | A |
| 2254620 | Miller | Sep 1941 | A |
| 2347956 | Lansing | May 1944 | A |
| 2355907 | Cox | Aug 1944 | A |
| 2421193 | Gardner | May 1947 | A |
| 2452734 | Costclow | Nov 1948 | A |
| 2472009 | Gardner | May 1949 | A |
| 2480271 | Sumner | Aug 1949 | A |
| 2572936 | Kulp et al. | Oct 1951 | A |
| 2591063 | Goldberg | Apr 1952 | A |
| 2684070 | Kelsey | Jul 1954 | A |
| 2736964 | Lieberman | Mar 1956 | A |
| 2779083 | Enton | Jan 1957 | A |
| 2814296 | Everett | Nov 1957 | A |
| 2817339 | Sullivan | Dec 1957 | A |
| 2866256 | Matlin | Dec 1958 | A |
| 2910067 | White | Oct 1959 | A |
| 2928395 | Forbes et al. | Mar 1960 | A |
| 2988028 | Alcamo | Jun 1961 | A |
| 3003155 | Mielzynski et al. | Oct 1961 | A |
| 3066452 | Bott et al. | Dec 1962 | A |
| 3066673 | Bott et al. | Dec 1962 | A |
| 3068869 | Shelden et al. | Dec 1962 | A |
| 3068870 | Levin | Dec 1962 | A |
| 3123077 | Alcamo | Mar 1964 | A |
| 3166072 | Sullivan, Jr. | Jan 1965 | A |
| 3187752 | Glick | Jun 1965 | A |
| 3206018 | Lewis et al. | Sep 1965 | A |
| 3209652 | Burgsmueller | Oct 1965 | A |
| 3209754 | Brown | Oct 1965 | A |
| 3212187 | Benedict | Oct 1965 | A |
| 3214810 | Mathison | Nov 1965 | A |
| 3221746 | Noble | Dec 1965 | A |
| 3234636 | Brown | Feb 1966 | A |
| 3273562 | Brown | Sep 1966 | A |
| 3352191 | Crawford | Nov 1967 | A |
| 3378010 | Codling | Apr 1968 | A |
| 3385299 | Leroy | May 1968 | A |
| 3394704 | Dery | Jul 1968 | A |
| 3494006 | Brumlik | Feb 1970 | A |
| 3522637 | Brumlik | Aug 1970 | A |
| 3525340 | Gilbert | Aug 1970 | A |
| 3527223 | Shein | Sep 1970 | A |
| 3545608 | Berger et al. | Dec 1970 | A |
| 3557795 | Hirsch | Jan 1971 | A |
| 3570497 | Lemole | Mar 1971 | A |
| 3586002 | Wood | Jun 1971 | A |
| 3608095 | Barry | Sep 1971 | A |
| 3608539 | Miller | Sep 1971 | A |
| 3618447 | Goins | Nov 1971 | A |
| 3646615 | Ness | Mar 1972 | A |
| 3683926 | Suzuki | Aug 1972 | A |
| 3700433 | Duhl | Oct 1972 | A |
| 3716058 | Tanner, Jr. | Feb 1973 | A |
| 3720055 | de Mestral et al. | Mar 1973 | A |
| 3748701 | De Mestral | Jul 1973 | A |
| 3762418 | Wasson | Oct 1973 | A |
| 3825010 | McDonald | Jul 1974 | A |
| 3833972 | Brumlik | Sep 1974 | A |
| 3845641 | Waller | Nov 1974 | A |
| 3847156 | Trumble | Nov 1974 | A |
| 3889322 | Brumlik | Jun 1975 | A |
| 3918455 | Coplan | Nov 1975 | A |
| 3922455 | Brumlik | Nov 1975 | A |
| 3941164 | Musgrave | Mar 1976 | A |
| 3963031 | Hunter | Jun 1976 | A |
| 3977937 | Candor | Aug 1976 | A |
| 3980177 | McGregor | Sep 1976 | A |
| 3981051 | Brumlik | Sep 1976 | A |
| 3981307 | Borysko | Sep 1976 | A |
| 3985138 | Jarvik | Oct 1976 | A |
| 3990144 | Schwartz | Nov 1976 | A |
| 4006747 | Kronenthal | Feb 1977 | A |
| 4008303 | Glick et al. | Feb 1977 | A |
| 4027608 | Arbuckle | Jun 1977 | A |
| 4043344 | Landi | Aug 1977 | A |
| 4052988 | Doddi et al. | Oct 1977 | A |
| D246911 | Bess, Jr. et al. | Jan 1978 | S |
| 4069825 | Akiyama | Jan 1978 | A |
| 4073298 | Le Roy | Feb 1978 | A |
| 4075962 | Mabry | Feb 1978 | A |
| 4098210 | Wright | Jul 1978 | A |
| 4137921 | Okuzumi et al. | Feb 1979 | A |
| 4182340 | Spencer | Jan 1980 | A |
| 4186239 | Mize et al. | Jan 1980 | A |
| 4198734 | Brumlik | Apr 1980 | A |
| 4204541 | Kapitanov | May 1980 | A |
| 4204542 | Bokros et al. | May 1980 | A |
| 4259959 | Walker | Apr 1981 | A |
| 4278374 | Wolosianski | Jul 1981 | A |
| 4300424 | Flinn | Nov 1981 | A |
| 4311002 | Hoffmann et al. | Jan 1982 | A |
| 4313448 | Stokes | Feb 1982 | A |
| 4316469 | Kapitanov | Feb 1982 | A |
| 4317451 | Cerwin et al. | Mar 1982 | A |
| 4372293 | Vijil-Rosales | Feb 1983 | A |
| 4428376 | Mericle | Jan 1984 | A |
| 4430998 | Harvey | Feb 1984 | A |
| 4434796 | Karapetian | Mar 1984 | A |
| 4449298 | Patz | May 1984 | A |
| 4454875 | Pratt et al. | Jun 1984 | A |
| 4467805 | Fukuda | Aug 1984 | A |
| 4490326 | Beroff et al. | Dec 1984 | A |
| 4492075 | Faure | Jan 1985 | A |
| 4493323 | Albright et al. | Jan 1985 | A |
| 4505274 | Speelman | Mar 1985 | A |
| 4510934 | Batra | Apr 1985 | A |
| 4531522 | Bedi et al. | Jul 1985 | A |
| 4532926 | O'Holla | Aug 1985 | A |
| 4535772 | Sheehan | Aug 1985 | A |
| 4548202 | Duncan | Oct 1985 | A |
| 4553544 | Nomoto et al. | Nov 1985 | A |
| 4610250 | Green | Sep 1986 | A |
| 4610251 | Kumar | Sep 1986 | A |
| 4635637 | Schreiber | Jan 1987 | A |
| 4637380 | Orejola | Jan 1987 | A |
| 4653486 | Coker | Mar 1987 | A |
| 4669473 | Richards et al. | Jun 1987 | A |
| 4676245 | Fukuda | Jun 1987 | A |
| 4689882 | Lorenz | Sep 1987 | A |
| 4702250 | Ovil et al. | Oct 1987 | A |
| 4712553 | MacGregor | Dec 1987 | A |
| 4719917 | Barrows | Jan 1988 | A |
| 4741330 | Hayhurst | May 1988 | A |
| 4750910 | Takayanagi et al. | Jun 1988 | A |
| 4776337 | Palmaz | Oct 1988 | A |
| 4832025 | Coates | May 1989 | A |
| 4841960 | Garner | Jun 1989 | A |
| 4865026 | Barrett | Sep 1989 | A |
| 4873976 | Schreiber | Oct 1989 | A |
| 4887601 | Richards | Dec 1989 | A |
| 4895148 | Bays et al. | Jan 1990 | A |
| 4898156 | Gatturna et al. | Feb 1990 | A |
| 4899743 | Nicholson et al. | Feb 1990 | A |
| 4900605 | Thorgersen et al. | Feb 1990 | A |
| 4905367 | Pinchuck et al. | Mar 1990 | A |
| 4930945 | Arai et al. | Jun 1990 | A |
| 4932962 | Yoon et al. | Jun 1990 | A |
| 4946468 | Li | Aug 1990 | A |
| 4948444 | Schultz et al. | Aug 1990 | A |
| 4950258 | Kawai et al. | Aug 1990 | A |
| 4950285 | Wilk | Aug 1990 | A |
| 4968315 | Gatturna | Nov 1990 | A |
| 4976715 | Bays et al. | Dec 1990 | A |
| 4979956 | Silvestrini et al. | Dec 1990 | A |
| 4981149 | Yoon | Jan 1991 | A |
| 4994073 | Green | Feb 1991 | A |
| 4994084 | Brennan | Feb 1991 | A |
| 4997439 | Chen | Mar 1991 | A |
| 5002550 | Li | Mar 1991 | A |
| 5002562 | Oberlander | Mar 1991 | A |
| 5007921 | Brown | Apr 1991 | A |
| 5007922 | Chen et al. | Apr 1991 | A |
| 5026390 | Brown | Jun 1991 | A |
| 5037422 | Hayhurst et al. | Aug 1991 | A |
| 5037433 | Wilk et al. | Aug 1991 | A |
| 5041129 | Hayhurst et al. | Aug 1991 | A |
| 5046513 | Gatturna et al. | Sep 1991 | A |
| 5047047 | Yoon | Sep 1991 | A |
| 5053047 | Yoon | Oct 1991 | A |
| 5084063 | Korthoff | Jan 1992 | A |
| 5089010 | Korthoff | Feb 1992 | A |
| 5089012 | Prou | Feb 1992 | A |
| 5102418 | Granger et al. | Apr 1992 | A |
| 5102421 | Anpach, Jr. | Apr 1992 | A |
| 5103073 | Danilov et al. | Apr 1992 | A |
| 5112344 | Petros | May 1992 | A |
| 5123911 | Granger et al. | Jun 1992 | A |
| 5123913 | Wilk et al. | Jun 1992 | A |
| 5123919 | Sauter et al. | Jun 1992 | A |
| 5127413 | Ebert | Jul 1992 | A |
| 5133738 | Korthoff et al. | Jul 1992 | A |
| 5141520 | Goble et al. | Aug 1992 | A |
| 5147382 | Gertzman et al. | Sep 1992 | A |
| 5156615 | Korthoff et al. | Oct 1992 | A |
| 5156788 | Chesterfield et al. | Oct 1992 | A |
| 5176692 | Wilk et al. | Jan 1993 | A |
| 5178629 | Kammerer | Jan 1993 | A |
| 5179964 | Cook | Jan 1993 | A |
| 5192274 | Bierman | Mar 1993 | A |
| 5192302 | Kensey et al. | Mar 1993 | A |
| 5192303 | Gatturna et al. | Mar 1993 | A |
| 5197597 | Leary et al. | Mar 1993 | A |
| 5201326 | Kubicki et al. | Apr 1993 | A |
| 5207679 | Li | May 1993 | A |
| 5207694 | Broome | May 1993 | A |
| 5217486 | Rice et al. | Jun 1993 | A |
| 5217494 | Coggins et al. | Jun 1993 | A |
| 5222508 | Contarini | Jun 1993 | A |
| 5222976 | Yoon | Jun 1993 | A |
| 5224946 | Hayhurst et al. | Jul 1993 | A |
| 5234006 | Eaton et al. | Aug 1993 | A |
| 5234445 | Walker | Aug 1993 | A |
| 5242457 | Akopov et al. | Sep 1993 | A |
| 5246441 | Ross et al. | Sep 1993 | A |
| 5258013 | Granger et al. | Nov 1993 | A |
| 5259846 | Granger et al. | Nov 1993 | A |
| 5263973 | Cook | Nov 1993 | A |
| 5269783 | Sander | Dec 1993 | A |
| 5282832 | Toso et al. | Feb 1994 | A |
| 5292326 | Green | Mar 1994 | A |
| 5306288 | Granger et al. | Apr 1994 | A |
| 5306290 | Martins et al. | Apr 1994 | A |
| 5312422 | Trott | May 1994 | A |
| 5320629 | Noda et al. | Jun 1994 | A |
| 5330488 | Goldrath | Jul 1994 | A |
| 5330503 | Yoon | Jul 1994 | A |
| 5336239 | Gimpelson | Aug 1994 | A |
| 5342376 | Ruff | Aug 1994 | A |
| 5342395 | Jarrett et al. | Aug 1994 | A |
| 5350385 | Christy | Sep 1994 | A |
| 5352515 | Jarrett et al. | Oct 1994 | A |
| 5354271 | Voda | Oct 1994 | A |
| 5354298 | Lee et al. | Oct 1994 | A |
| 5358511 | Gatturna et al. | Oct 1994 | A |
| 5363556 | Banholzer et al. | Nov 1994 | A |
| 5372146 | Branch | Dec 1994 | A |
| 5374268 | Sander | Dec 1994 | A |
| 5374278 | Chesterfield et al. | Dec 1994 | A |
| 5380334 | Torrie et al. | Jan 1995 | A |
| 5391173 | Wilk | Feb 1995 | A |
| 5403346 | Loeser | Apr 1995 | A |
| 5411523 | Goble | May 1995 | A |
| 5414988 | DiPalma et al. | May 1995 | A |
| 5417691 | Hayhurst | May 1995 | A |
| 5425746 | Proto et al. | Jun 1995 | A |
| 5425747 | Brotz | Jun 1995 | A |
| 5437680 | Yoon et al. | Aug 1995 | A |
| 5450860 | O'Connor | Sep 1995 | A |
| 5451461 | Broyer | Sep 1995 | A |
| 5462561 | Voda | Oct 1995 | A |
| 5464422 | Silverman | Nov 1995 | A |
| 5464426 | Bonutti | Nov 1995 | A |
| 5464427 | Curtis et al. | Nov 1995 | A |
| 5466241 | Leroy et al. | Nov 1995 | A |
| 5472452 | Trott | Dec 1995 | A |
| 5478353 | Yoon | Dec 1995 | A |
| 5480403 | Lee et al. | Jan 1996 | A |
| 5480411 | Liu et al. | Jan 1996 | A |
| 5484451 | Akopov et al. | Jan 1996 | A |
| 5486197 | Le et al. | Jan 1996 | A |
| 5500000 | Feagin et al. | Mar 1996 | A |
| 5500991 | Demarest et al. | Mar 1996 | A |
| 5520084 | Chesterfield et al. | May 1996 | A |
| 5520691 | Branch | May 1996 | A |
| 5522845 | Wenstrom, Jr. | Jun 1996 | A |
| 5527342 | Pietrzak et al. | Jun 1996 | A |
| 5531760 | Alwafaie | Jul 1996 | A |
| 5531761 | Yoon | Jul 1996 | A |
| 5531790 | Frechet et al. | Jul 1996 | A |
| 5533982 | Rizk et al. | Jul 1996 | A |
| 5536582 | Prasad et al. | Jul 1996 | A |
| 5540705 | Meade et al. | Jul 1996 | A |
| 5540718 | Bartlett | Jul 1996 | A |
| 5545148 | Wurster | Aug 1996 | A |
| 5546957 | Heske | Aug 1996 | A |
| 5549631 | Bonutti | Aug 1996 | A |
| 5554171 | Gatturna et al. | Sep 1996 | A |
| 5569272 | Reed et al. | Oct 1996 | A |
| 5571139 | Jenkins, Jr. | Nov 1996 | A |
| 5571175 | Vanney et al. | Nov 1996 | A |
| 5571216 | Anderson | Nov 1996 | A |
| 5573543 | Akopov et al. | Nov 1996 | A |
| 5584859 | Brotz | Dec 1996 | A |
| 5593424 | Northrup, III et al. | Jan 1997 | A |
| 5601557 | Hayhurst | Feb 1997 | A |
| 5626590 | Wilk | May 1997 | A |
| 5626611 | Liu et al. | May 1997 | A |
| 5632753 | Loeser | May 1997 | A |
| 5643288 | Thompson | Jul 1997 | A |
| 5643295 | Yoon | Jul 1997 | A |
| 5643319 | Green et al. | Jul 1997 | A |
| 5645568 | Chervitz et al. | Jul 1997 | A |
| 5647874 | Hayhurst | Jul 1997 | A |
| 5649939 | Reddick | Jul 1997 | A |
| 5653716 | Malo et al. | Aug 1997 | A |
| 5662654 | Thompson | Sep 1997 | A |
| 5662714 | Charvin et al. | Sep 1997 | A |
| 5669935 | Rosenman et al. | Sep 1997 | A |
| D386583 | McFerragamo et al. | Nov 1997 | S |
| 5676675 | Grice | Nov 1997 | A |
| 5683417 | Cooper | Nov 1997 | A |
| D387161 | McFerragamo et al. | Dec 1997 | S |
| 5693072 | McIntosh | Dec 1997 | A |
| 5695879 | Goldmann et al. | Dec 1997 | A |
| 5697976 | Chesterfield et al. | Dec 1997 | A |
| 5702397 | Goble et al. | Dec 1997 | A |
| 5702462 | Oberlander | Dec 1997 | A |
| 5709692 | Mollenauer et al. | Jan 1998 | A |
| 5716358 | Ochoa et al. | Feb 1998 | A |
| 5716376 | Roby et al. | Feb 1998 | A |
| 5722991 | Colligan | Mar 1998 | A |
| 5723008 | Gordon | Mar 1998 | A |
| 5725557 | Gatturna et al. | Mar 1998 | A |
| 5728114 | Evans et al. | Mar 1998 | A |
| 5731855 | Koyama et al. | Mar 1998 | A |
| 5741277 | Gordon et al. | Apr 1998 | A |
| 5744151 | Capelli | Apr 1998 | A |
| 5763411 | Edwardson et al. | Jun 1998 | A |
| 5765560 | Verkerke et al. | Jun 1998 | A |
| 5766246 | Mulhauser et al. | Jun 1998 | A |
| 5779719 | Klein et al. | Jul 1998 | A |
| 5782864 | Lizardi | Jul 1998 | A |
| 5807403 | Boyar et al. | Sep 1998 | A |
| 5807406 | Brauker et al. | Sep 1998 | A |
| 5810853 | Yoon | Sep 1998 | A |
| 5814051 | Wenstrom, Jr. | Sep 1998 | A |
| 5843087 | Jensen et al. | Dec 1998 | A |
| 5843178 | Vanney et al. | Dec 1998 | A |
| 5855619 | Caplan et al. | Jan 1999 | A |
| 5863360 | Wood et al. | Jan 1999 | A |
| 5887594 | Locicero, III | Mar 1999 | A |
| 5891166 | Schervinsky | Apr 1999 | A |
| 5893856 | Jacob et al. | Apr 1999 | A |
| 5895395 | Yeung | Apr 1999 | A |
| 5895413 | Nordstrom | Apr 1999 | A |
| 5897572 | Schulsinger et al. | Apr 1999 | A |
| 5899911 | Carter | May 1999 | A |
| 5916224 | Esplin | Jun 1999 | A |
| 5919234 | Lemperle et al. | Jul 1999 | A |
| 5921982 | Lesh et al. | Jul 1999 | A |
| 5925078 | Anderson | Jul 1999 | A |
| 5931855 | Buncke | Aug 1999 | A |
| 5935138 | McJames, II et al. | Aug 1999 | A |
| 5938668 | Scirica et al. | Aug 1999 | A |
| 5941899 | Granger et al. | Aug 1999 | A |
| 5950633 | Lynch et al. | Sep 1999 | A |
| 5954747 | Clark | Sep 1999 | A |
| 5964765 | Fenton, Jr. et al. | Oct 1999 | A |
| 5964783 | Grafton et al. | Oct 1999 | A |
| 5968097 | Frechet et al. | Oct 1999 | A |
| 5972024 | Northrup, III et al. | Oct 1999 | A |
| 5984933 | Yoon | Nov 1999 | A |
| 5993459 | Larsen et al. | Nov 1999 | A |
| 5997554 | Thompson | Dec 1999 | A |
| 6001111 | Sepetka et al. | Dec 1999 | A |
| 6012216 | Esteves et al. | Jan 2000 | A |
| 6015410 | Tormala et al. | Jan 2000 | A |
| 6024757 | Haase et al. | Feb 2000 | A |
| 6027523 | Schmieding | Feb 2000 | A |
| 6039741 | Meislin | Mar 2000 | A |
| 6042583 | Thompson et al. | Mar 2000 | A |
| 6045571 | Hill et al. | Apr 2000 | A |
| 6056778 | Grafton et al. | May 2000 | A |
| 6063105 | Totakura | May 2000 | A |
| 6071292 | Makower et al. | Jun 2000 | A |
| 6074419 | Healy et al. | Jun 2000 | A |
| 6076255 | Shikakubo et al. | Jun 2000 | A |
| 6083244 | Lubbers et al. | Jul 2000 | A |
| 6102947 | Gordon | Aug 2000 | A |
| 6106544 | Brazeau | Aug 2000 | A |
| 6106545 | Egan | Aug 2000 | A |
| 6110484 | Sierra | Aug 2000 | A |
| 6129741 | Wurster et al. | Oct 2000 | A |
| D433753 | Weiss | Nov 2000 | S |
| 6146406 | Shluzas et al. | Nov 2000 | A |
| 6146407 | Krebs | Nov 2000 | A |
| 6149660 | Laufer et al. | Nov 2000 | A |
| 6159234 | Bonutti et al. | Dec 2000 | A |
| 6160084 | Langer et al. | Dec 2000 | A |
| 6163948 | Esteves et al. | Dec 2000 | A |
| 6165203 | Krebs | Dec 2000 | A |
| 6168633 | Shoher et al. | Jan 2001 | B1 |
| 6174324 | Egan et al. | Jan 2001 | B1 |
| 6183499 | Fischer et al. | Feb 2001 | B1 |
| 6187095 | Labrecque et al. | Feb 2001 | B1 |
| 6203565 | Bonutti et al. | Mar 2001 | B1 |
| 6206908 | Roby | Mar 2001 | B1 |
| 6214030 | Matsutani et al. | Apr 2001 | B1 |
| 6231911 | Steinback et al. | May 2001 | B1 |
| 6235869 | Roby et al. | May 2001 | B1 |
| 6241747 | Ruff | Jun 2001 | B1 |
| 6251143 | Schwartz et al. | Jun 2001 | B1 |
| 6264675 | Brotz | Jul 2001 | B1 |
| 6267772 | Mulhauser et al. | Jul 2001 | B1 |
| 6270517 | Brotz | Aug 2001 | B1 |
| 6315788 | Roby | Nov 2001 | B1 |
| 6319231 | Andrulitis | Nov 2001 | B1 |
| 6322581 | Fukuda et al. | Nov 2001 | B1 |
| 6334865 | Redmond et al. | Jan 2002 | B1 |
| 6383201 | Dong | May 2002 | B1 |
| 6387363 | Gruskin | May 2002 | B1 |
| 6388043 | Langer et al. | May 2002 | B1 |
| 6395029 | Levy | May 2002 | B1 |
| D462766 | Jacobs et al. | Sep 2002 | S |
| 6443962 | Gaber | Sep 2002 | B1 |
| 6471715 | Weiss | Oct 2002 | B1 |
| 6475229 | Pagedas | Nov 2002 | B1 |
| 6478809 | Brotz | Nov 2002 | B1 |
| 6485503 | Jacobs et al. | Nov 2002 | B2 |
| 6491701 | Tierney et al. | Dec 2002 | B2 |
| 6491714 | Bennett | Dec 2002 | B1 |
| 6494898 | Roby et al. | Dec 2002 | B1 |
| 6495127 | Wallace et al. | Dec 2002 | B1 |
| RE37963 | Thal | Jan 2003 | E |
| 6506190 | Walshe | Jan 2003 | B1 |
| 6506197 | Rollero et al. | Jan 2003 | B1 |
| 6511488 | Marshall et al. | Jan 2003 | B1 |
| 6514265 | Ho et al. | Feb 2003 | B2 |
| 6527795 | Lizardi | Mar 2003 | B1 |
| 6548002 | Gresser et al. | Apr 2003 | B2 |
| 6548569 | Williams et al. | Apr 2003 | B1 |
| 6551343 | Tormala et al. | Apr 2003 | B1 |
| 6554802 | Pearson et al. | Apr 2003 | B1 |
| 6565597 | Fearnot et al. | May 2003 | B1 |
| 6592609 | Bonutti | Jul 2003 | B1 |
| 6596296 | Nelson et al. | Jul 2003 | B1 |
| 6599310 | Leung et al. | Jul 2003 | B2 |
| 6607541 | Gardiner et al. | Aug 2003 | B1 |
| 6610078 | Bru-Magniez et al. | Aug 2003 | B1 |
| 6613059 | Schaller et al. | Sep 2003 | B2 |
| 6613254 | Shiffer | Sep 2003 | B1 |
| 6616982 | Merrill et al. | Sep 2003 | B2 |
| 6623492 | Berube et al. | Sep 2003 | B1 |
| 6626930 | Allen et al. | Sep 2003 | B1 |
| 6632245 | Kim | Oct 2003 | B2 |
| 6641592 | Sauer et al. | Nov 2003 | B1 |
| 6641593 | Schaller et al. | Nov 2003 | B1 |
| 6645226 | Jacobs et al. | Nov 2003 | B1 |
| 6645227 | Fallin et al. | Nov 2003 | B2 |
| 6648921 | Anderson et al. | Nov 2003 | B2 |
| 6656182 | Hayhurst | Dec 2003 | B1 |
| 6689153 | Skiba | Feb 2004 | B1 |
| 6689166 | Laurencin et al. | Feb 2004 | B2 |
| 6692761 | Mahmood et al. | Feb 2004 | B2 |
| 6702844 | Lazarus | Mar 2004 | B1 |
| 6712830 | Esplin | Mar 2004 | B2 |
| 6712859 | Rousseau et al. | Mar 2004 | B2 |
| 6716234 | Grafton et al. | Apr 2004 | B2 |
| 6720402 | Langer et al. | Apr 2004 | B2 |
| 6726705 | Peterson et al. | Apr 2004 | B2 |
| 6746443 | Morley et al. | Jun 2004 | B1 |
| 6746458 | Cloud | Jun 2004 | B1 |
| 6749616 | Nath | Jun 2004 | B1 |
| 6773450 | Leung et al. | Aug 2004 | B2 |
| 6783554 | Amara et al. | Aug 2004 | B2 |
| 6814748 | Baker et al. | Nov 2004 | B1 |
| 6818010 | Eichhorn et al. | Nov 2004 | B2 |
| 6838493 | Williams et al. | Jan 2005 | B2 |
| 6848152 | Genova et al. | Feb 2005 | B2 |
| 6852825 | Lendlein et al. | Feb 2005 | B2 |
| 6860891 | Schulze | Mar 2005 | B2 |
| 6860901 | Baker et al. | Mar 2005 | B1 |
| 6867248 | Martin et al. | Mar 2005 | B1 |
| 6877934 | Gainer | Apr 2005 | B2 |
| 6881766 | Hain | Apr 2005 | B2 |
| 6893452 | Jacobs | May 2005 | B2 |
| 6905484 | Buckman et al. | Jun 2005 | B2 |
| 6911035 | Blomme | Jun 2005 | B1 |
| 6911037 | Gainor et al. | Jun 2005 | B2 |
| 6913607 | Ainsworth et al. | Jul 2005 | B2 |
| 6921811 | Zamora et al. | Jul 2005 | B2 |
| 6923819 | Meade et al. | Aug 2005 | B2 |
| 6945021 | Michel | Sep 2005 | B2 |
| 6945980 | Nguyen et al. | Sep 2005 | B2 |
| 6960221 | Ho et al. | Nov 2005 | B2 |
| 6960233 | Berg et al. | Nov 2005 | B1 |
| 6974450 | Weber et al. | Dec 2005 | B2 |
| 6981983 | Rosenblatt et al. | Jan 2006 | B1 |
| 6984241 | Lubbers et al. | Jan 2006 | B2 |
| 6986780 | Rudnick et al. | Jan 2006 | B2 |
| 6991643 | Saadat | Jan 2006 | B2 |
| 6996880 | Kurtz, Jr. | Feb 2006 | B2 |
| 7021316 | Leiboff | Apr 2006 | B2 |
| 7033379 | Peterson | Apr 2006 | B2 |
| 7037984 | Ledlein et al. | May 2006 | B2 |
| 7048748 | Ustuner | May 2006 | B1 |
| 7056331 | Kaplan et al. | Jun 2006 | B2 |
| 7056333 | Walshe | Jun 2006 | B2 |
| 7057135 | Li | Jun 2006 | B2 |
| 7063716 | Cunningham | Jun 2006 | B2 |
| 7070610 | Im et al. | Jul 2006 | B2 |
| 7081135 | Smith et al. | Jul 2006 | B2 |
| 7083637 | Tannhauser | Aug 2006 | B1 |
| 7083648 | Yu et al. | Aug 2006 | B2 |
| 7107090 | Salisbury, Jr. et al. | Sep 2006 | B2 |
| 7112214 | Peterson et al. | Sep 2006 | B2 |
| 7125403 | Julian et al. | Oct 2006 | B2 |
| 7125413 | Grigoryants et al. | Oct 2006 | B2 |
| D532107 | Peterson et al. | Nov 2006 | S |
| 7138441 | Zhang | Nov 2006 | B1 |
| 7141302 | Mueller et al. | Nov 2006 | B2 |
| 7144401 | Yamamoto et al. | Dec 2006 | B2 |
| 7144412 | Wolf et al. | Dec 2006 | B2 |
| 7144415 | DelRio et al. | Dec 2006 | B2 |
| 7150757 | Fallin et al. | Dec 2006 | B2 |
| 7156858 | Schuldt-Hempe et al. | Jan 2007 | B2 |
| 7156862 | Jacobs et al. | Jan 2007 | B2 |
| 7160312 | Saadat | Jan 2007 | B2 |
| 7172595 | Goble | Feb 2007 | B1 |
| 7172615 | Morriss et al. | Feb 2007 | B2 |
| 7186262 | Saadat | Mar 2007 | B2 |
| 7195634 | Schmieding et al. | Mar 2007 | B2 |
| 7211088 | Grafton et al. | May 2007 | B2 |
| 7214230 | Brock et al. | May 2007 | B2 |
| 7217744 | Lendlein et al. | May 2007 | B2 |
| 7225512 | Genova et al. | Jun 2007 | B2 |
| 7226468 | Ruff | Jun 2007 | B2 |
| 7232447 | Gellman et al. | Jun 2007 | B2 |
| 7244270 | Lesh et al. | Jul 2007 | B2 |
| 7279612 | Heaton et al. | Oct 2007 | B1 |
| 7297142 | Brock | Nov 2007 | B2 |
| 7322105 | Lewis | Jan 2008 | B2 |
| 7329271 | Koyfman et al. | Feb 2008 | B2 |
| 7371253 | Leung et al. | May 2008 | B2 |
| 7381211 | Zamierowski | Jun 2008 | B2 |
| 7513904 | Sulamanidze et al. | Apr 2009 | B2 |
| 7582105 | Kolster | Sep 2009 | B2 |
| 7601164 | Wu | Oct 2009 | B2 |
| 7624487 | Trull et al. | Dec 2009 | B2 |
| 7645293 | Martinek et al. | Jan 2010 | B2 |
| 7806908 | Ruff | Oct 2010 | B2 |
| 7845356 | Paraschac et al. | Dec 2010 | B2 |
| 7857829 | Kaplan et al. | Dec 2010 | B2 |
| 7871425 | Jones et al. | Jan 2011 | B2 |
| 7879072 | Bonutti et al. | Feb 2011 | B2 |
| 7919112 | Pathak et al. | Apr 2011 | B2 |
| 8083770 | Ruff et al. | Dec 2011 | B2 |
| 8100940 | Leung et al. | Jan 2012 | B2 |
| 8118834 | Goraltchouk et al. | Feb 2012 | B1 |
| 8216273 | Goraltchouk et al. | Jul 2012 | B1 |
| 8225673 | D'Agostino | Jul 2012 | B2 |
| 8226684 | Nawrocki et al. | Jul 2012 | B2 |
| 8246652 | Ruff | Aug 2012 | B2 |
| 8256613 | Kirsch et al. | Sep 2012 | B2 |
| 8308761 | Brailovski et al. | Nov 2012 | B2 |
| 8402621 | Maiorino et al. | Mar 2013 | B2 |
| 8459446 | Kozlowski | Jun 2013 | B2 |
| 8460338 | Goraltchouk et al. | Jun 2013 | B2 |
| 8641732 | Goraltchouk et al. | Feb 2014 | B1 |
| 8652170 | Leung et al. | Feb 2014 | B2 |
| 8679158 | Leung et al. | Mar 2014 | B2 |
| 8721664 | Ruff | May 2014 | B2 |
| 20010011187 | Pavcnik et al. | Aug 2001 | A1 |
| 20010018592 | Schaller et al. | Aug 2001 | A1 |
| 20010018599 | D'Aversa et al. | Aug 2001 | A1 |
| 20010039450 | Pavcnik et al. | Nov 2001 | A1 |
| 20010051807 | Grafton | Dec 2001 | A1 |
| 20020007218 | Cauthen | Jan 2002 | A1 |
| 20020022861 | Jacobs | Feb 2002 | A1 |
| 20020029011 | Dyer | Mar 2002 | A1 |
| 20020029066 | Foerster | Mar 2002 | A1 |
| 20020077448 | Antal et al. | Jun 2002 | A1 |
| 20020095164 | Andreas et al. | Jul 2002 | A1 |
| 20020099394 | Houser et al. | Jul 2002 | A1 |
| 20020111641 | Peterson et al. | Aug 2002 | A1 |
| 20020111688 | Cauthen | Aug 2002 | A1 |
| 20020138009 | Brockway et al. | Sep 2002 | A1 |
| 20020151932 | Bryant et al. | Oct 2002 | A1 |
| 20020151980 | Cauthen | Oct 2002 | A1 |
| 20020161168 | Shalaby et al. | Oct 2002 | A1 |
| 20020165555 | Stein et al. | Nov 2002 | A1 |
| 20020173822 | Justin et al. | Nov 2002 | A1 |
| 20020179718 | Murokh et al. | Dec 2002 | A1 |
| 20030040795 | Elson et al. | Feb 2003 | A1 |
| 20030069602 | Jacobs et al. | Apr 2003 | A1 |
| 20030088270 | Lubbers et al. | May 2003 | A1 |
| 20030149447 | Morency | Aug 2003 | A1 |
| 20030158604 | Cauthen, III et al. | Aug 2003 | A1 |
| 20030167072 | Oberlander | Sep 2003 | A1 |
| 20030199923 | Khairkhahan et al. | Oct 2003 | A1 |
| 20030203003 | Nelson et al. | Oct 2003 | A1 |
| 20030204193 | Gabriel et al. | Oct 2003 | A1 |
| 20030204195 | Keane et al. | Oct 2003 | A1 |
| 20030225424 | Benderev | Dec 2003 | A1 |
| 20030229361 | Jackson | Dec 2003 | A1 |
| 20030236551 | Peterson | Dec 2003 | A1 |
| 20040006353 | Bosley, Jr. et al. | Jan 2004 | A1 |
| 20040010275 | Jacobs et al. | Jan 2004 | A1 |
| 20040010276 | Jacobs et al. | Jan 2004 | A1 |
| 20040015187 | Lendlein et al. | Jan 2004 | A1 |
| 20040024169 | Shalaby et al. | Feb 2004 | A1 |
| 20040024420 | Lubbers et al. | Feb 2004 | A1 |
| 20040030354 | Leung et al. | Feb 2004 | A1 |
| 20040039415 | Zamierowski | Feb 2004 | A1 |
| 20040049224 | Buehlmann et al. | Mar 2004 | A1 |
| 20040059370 | Greene, Jr. et al. | Mar 2004 | A1 |
| 20040059377 | Peterson et al. | Mar 2004 | A1 |
| 20040060409 | Leung et al. | Apr 2004 | A1 |
| 20040060410 | Leung et al. | Apr 2004 | A1 |
| 20040068293 | Scalzo et al. | Apr 2004 | A1 |
| 20040068294 | Scalzo et al. | Apr 2004 | A1 |
| 20040088003 | Leung et al. | May 2004 | A1 |
| 20040093023 | Allen et al. | May 2004 | A1 |
| 20040098051 | Fallin et al. | May 2004 | A1 |
| 20040106949 | Cohn et al. | Jun 2004 | A1 |
| 20040116620 | Shalaby et al. | Jun 2004 | A1 |
| 20040138683 | Shelton et al. | Jul 2004 | A1 |
| 20040153153 | Elson et al. | Aug 2004 | A1 |
| 20040167572 | Roth et al. | Aug 2004 | A1 |
| 20040167575 | Roby | Aug 2004 | A1 |
| 20040186487 | Klein et al. | Sep 2004 | A1 |
| 20040193191 | Starksen et al. | Sep 2004 | A1 |
| 20040193217 | Lubbers et al. | Sep 2004 | A1 |
| 20040193257 | Wu et al. | Sep 2004 | A1 |
| 20040230223 | Bonutti et al. | Nov 2004 | A1 |
| 20040260340 | Jacobs et al. | Dec 2004 | A1 |
| 20040265282 | Wright et al. | Dec 2004 | A1 |
| 20040267309 | Garvin | Dec 2004 | A1 |
| 20050004601 | Kong et al. | Jan 2005 | A1 |
| 20050004602 | Hart et al. | Jan 2005 | A1 |
| 20050033324 | Phan | Feb 2005 | A1 |
| 20050034431 | Dey et al. | Feb 2005 | A1 |
| 20050038472 | Furst | Feb 2005 | A1 |
| 20050049636 | Leiboff | Mar 2005 | A1 |
| 20050055051 | Grafton | Mar 2005 | A1 |
| 20050059984 | Chanduszko et al. | Mar 2005 | A1 |
| 20050065533 | Magen et al. | Mar 2005 | A1 |
| 20050070959 | Cichocki, Jr. | Mar 2005 | A1 |
| 20050080455 | Schmieding et al. | Apr 2005 | A1 |
| 20050085857 | Peterson et al. | Apr 2005 | A1 |
| 20050096698 | Lederman | May 2005 | A1 |
| 20050113936 | Brustad et al. | May 2005 | A1 |
| 20050119694 | Jacobs et al. | Jun 2005 | A1 |
| 20050125020 | Meade et al. | Jun 2005 | A1 |
| 20050125034 | Cichocki, Jr. | Jun 2005 | A1 |
| 20050125035 | Cichocki, Jr. | Jun 2005 | A1 |
| 20050149064 | Peterson et al. | Jun 2005 | A1 |
| 20050149118 | Koyfman et al. | Jul 2005 | A1 |
| 20050154255 | Jacobs | Jul 2005 | A1 |
| 20050171561 | Songer et al. | Aug 2005 | A1 |
| 20050177190 | Zamierowski | Aug 2005 | A1 |
| 20050181009 | Hunter et al. | Aug 2005 | A1 |
| 20050182444 | Peterson et al. | Aug 2005 | A1 |
| 20050182445 | Zamierowski | Aug 2005 | A1 |
| 20050186247 | Hunter et al. | Aug 2005 | A1 |
| 20050197699 | Jacobs et al. | Sep 2005 | A1 |
| 20050199249 | Karram | Sep 2005 | A1 |
| 20050203576 | Sulamanidze et al. | Sep 2005 | A1 |
| 20050209542 | Jacobs et al. | Sep 2005 | A1 |
| 20050209612 | Nakao | Sep 2005 | A1 |
| 20050234510 | Zamierowski | Oct 2005 | A1 |
| 20050240220 | Zamierowski | Oct 2005 | A1 |
| 20050267531 | Ruff | Dec 2005 | A1 |
| 20050267532 | Wu | Dec 2005 | A1 |
| 20050277984 | Long | Dec 2005 | A1 |
| 20050283246 | Cauthen, III et al. | Dec 2005 | A1 |
| 20060020272 | Gildenberg | Jan 2006 | A1 |
| 20060030884 | Young et al. | Feb 2006 | A1 |
| 20060036266 | Sulamanidze et al. | Feb 2006 | A1 |
| 20060058470 | Rizk | Mar 2006 | A1 |
| 20060058574 | Priewe et al. | Mar 2006 | A1 |
| 20060058799 | Elson et al. | Mar 2006 | A1 |
| 20060058844 | White et al. | Mar 2006 | A1 |
| 20060063476 | Dore | Mar 2006 | A1 |
| 20060064115 | Allen et al. | Mar 2006 | A1 |
| 20060064116 | Allen et al. | Mar 2006 | A1 |
| 20060064127 | Fallin et al. | Mar 2006 | A1 |
| 20060079469 | Anderson et al. | Apr 2006 | A1 |
| 20060079935 | Kolster | Apr 2006 | A1 |
| 20060085016 | Eremia | Apr 2006 | A1 |
| 20060089525 | Mamo et al. | Apr 2006 | A1 |
| 20060089672 | Martinek | Apr 2006 | A1 |
| 20060106278 | Machold et al. | May 2006 | A1 |
| 20060111734 | Kaplan et al. | May 2006 | A1 |
| 20060111742 | Kaplan et al. | May 2006 | A1 |
| 20060116503 | Lendlein et al. | Jun 2006 | A1 |
| 20060122608 | Fallin et al. | Jun 2006 | A1 |
| 20060135994 | Ruff | Jun 2006 | A1 |
| 20060135995 | Ruff | Jun 2006 | A1 |
| 20060140999 | Lendlein et al. | Jun 2006 | A1 |
| 20060142784 | Kontos | Jun 2006 | A1 |
| 20060193769 | Nelson et al. | Aug 2006 | A1 |
| 20060194721 | Allen | Aug 2006 | A1 |
| 20060200062 | Saadat | Sep 2006 | A1 |
| 20060207612 | Jackson et al. | Sep 2006 | A1 |
| 20060229671 | Steiner et al. | Oct 2006 | A1 |
| 20060235445 | Birk et al. | Oct 2006 | A1 |
| 20060235447 | Walshe | Oct 2006 | A1 |
| 20060235516 | Cavazzoni | Oct 2006 | A1 |
| 20060241658 | Cerundolo | Oct 2006 | A1 |
| 20060249405 | Cerwin et al. | Nov 2006 | A1 |
| 20060253126 | Bjerken et al. | Nov 2006 | A1 |
| 20060257629 | Lendlein et al. | Nov 2006 | A1 |
| 20060258938 | Hoffman et al. | Nov 2006 | A1 |
| 20060272979 | Lubbers et al. | Dec 2006 | A1 |
| 20060276808 | Arnal et al. | Dec 2006 | A1 |
| 20060282099 | Stokes et al. | Dec 2006 | A1 |
| 20060286289 | Prajapati et al. | Dec 2006 | A1 |
| 20060287675 | Prajapati et al. | Dec 2006 | A1 |
| 20060287676 | Prajapati et al. | Dec 2006 | A1 |
| 20060293710 | Foerster et al. | Dec 2006 | A1 |
| 20070005109 | Popadiuk et al. | Jan 2007 | A1 |
| 20070005110 | Collier et al. | Jan 2007 | A1 |
| 20070016251 | Roby | Jan 2007 | A1 |
| 20070021779 | Garvin et al. | Jan 2007 | A1 |
| 20070027475 | Pagedas | Feb 2007 | A1 |
| 20070038249 | Kolster | Feb 2007 | A1 |
| 20070065663 | Trull et al. | Mar 2007 | A1 |
| 20070088135 | Lendlein et al. | Apr 2007 | A1 |
| 20070088391 | McAlexander et al. | Apr 2007 | A1 |
| 20070134292 | Suokas et al. | Jun 2007 | A1 |
| 20070135840 | Schmieding | Jun 2007 | A1 |
| 20070135843 | Burkhart | Jun 2007 | A1 |
| 20070151961 | Kleine et al. | Jul 2007 | A1 |
| 20070156175 | Weadock et al. | Jul 2007 | A1 |
| 20070167958 | Sulamanidze et al. | Jul 2007 | A1 |
| 20070185494 | Reese | Aug 2007 | A1 |
| 20070187861 | Geneva et al. | Aug 2007 | A1 |
| 20070208355 | Ruff | Sep 2007 | A1 |
| 20070208377 | Kaplan et al. | Sep 2007 | A1 |
| 20070213770 | Dreyfuss | Sep 2007 | A1 |
| 20070219587 | Accardo | Sep 2007 | A1 |
| 20070224237 | Hwang et al. | Sep 2007 | A1 |
| 20070225642 | Houser et al. | Sep 2007 | A1 |
| 20070225761 | Shetty | Sep 2007 | A1 |
| 20070225763 | Zwolinski et al. | Sep 2007 | A1 |
| 20070225764 | Benavitz et al. | Sep 2007 | A1 |
| 20070233188 | Hunt et al. | Oct 2007 | A1 |
| 20070239206 | Shelton, IV et al. | Oct 2007 | A1 |
| 20070239207 | Beramendi | Oct 2007 | A1 |
| 20070257395 | Lindh | Nov 2007 | A1 |
| 20070282247 | Desai et al. | Dec 2007 | A1 |
| 20070293892 | Takasu | Dec 2007 | A1 |
| 20080004490 | Bosley, Jr. et al. | Jan 2008 | A1 |
| 20080004603 | Larkin et al. | Jan 2008 | A1 |
| 20080009838 | Schena et al. | Jan 2008 | A1 |
| 20080009888 | Ewers et al. | Jan 2008 | A1 |
| 20080009902 | Hunter et al. | Jan 2008 | A1 |
| 20080027273 | Gutterman | Jan 2008 | A1 |
| 20080027486 | Jones et al. | Jan 2008 | A1 |
| 20080046094 | Han et al. | Feb 2008 | A1 |
| 20080058869 | Stopek et al. | Mar 2008 | A1 |
| 20080064839 | Hadba et al. | Mar 2008 | A1 |
| 20080066764 | Paraschac et al. | Mar 2008 | A1 |
| 20080066765 | Paraschac et al. | Mar 2008 | A1 |
| 20080066766 | Paraschac et al. | Mar 2008 | A1 |
| 20080066767 | Paraschac et al. | Mar 2008 | A1 |
| 20080077181 | Jones et al. | Mar 2008 | A1 |
| 20080082113 | Bishop et al. | Apr 2008 | A1 |
| 20080082129 | Jones et al. | Apr 2008 | A1 |
| 20080086169 | Jones et al. | Apr 2008 | A1 |
| 20080086170 | Jones et al. | Apr 2008 | A1 |
| 20080109036 | Stopek et al. | May 2008 | A1 |
| 20080131692 | Rolland et al. | Jun 2008 | A1 |
| 20080132943 | Maiorino | Jun 2008 | A1 |
| 20080169059 | Messersmith et al. | Jul 2008 | A1 |
| 20080195147 | Stopek | Aug 2008 | A1 |
| 20080208358 | Bellamkonda et al. | Aug 2008 | A1 |
| 20080215072 | Kelly | Sep 2008 | A1 |
| 20080221618 | Chen et al. | Sep 2008 | A1 |
| 20080234731 | Leung et al. | Sep 2008 | A1 |
| 20080248216 | Yeung et al. | Oct 2008 | A1 |
| 20080255611 | Hunter | Oct 2008 | A1 |
| 20080255612 | Hunter | Oct 2008 | A1 |
| 20080262542 | Sulamanidze et al. | Oct 2008 | A1 |
| 20080281338 | Wohlert et al. | Nov 2008 | A1 |
| 20080281357 | Sung et al. | Nov 2008 | A1 |
| 20080312688 | Nawrocki et al. | Dec 2008 | A1 |
| 20090012560 | Hunter et al. | Jan 2009 | A1 |
| 20090018577 | Leung et al. | Jan 2009 | A1 |
| 20090043336 | Yuan et al. | Feb 2009 | A1 |
| 20090076543 | Maiorino et al. | Mar 2009 | A1 |
| 20090082856 | Flanagan | Mar 2009 | A1 |
| 20090088835 | Wang | Apr 2009 | A1 |
| 20090099597 | Isse | Apr 2009 | A1 |
| 20090105753 | Greenhalgh et al. | Apr 2009 | A1 |
| 20090107965 | D'Agostino | Apr 2009 | A1 |
| 20090112236 | Stopek | Apr 2009 | A1 |
| 20090112259 | D'Agostino | Apr 2009 | A1 |
| 20090143819 | D'Agostino | Jun 2009 | A1 |
| 20090200487 | Maiorino et al. | Aug 2009 | A1 |
| 20090210006 | Cohen et al. | Aug 2009 | A1 |
| 20090216253 | Bell et al. | Aug 2009 | A1 |
| 20090226500 | Avelar et al. | Sep 2009 | A1 |
| 20090228021 | Leung | Sep 2009 | A1 |
| 20090248066 | Wilkie | Oct 2009 | A1 |
| 20090248067 | Maiorino | Oct 2009 | A1 |
| 20090248070 | Kosa et al. | Oct 2009 | A1 |
| 20090250588 | Robeson et al. | Oct 2009 | A1 |
| 20090259233 | Bogart et al. | Oct 2009 | A1 |
| 20090259251 | Cohen | Oct 2009 | A1 |
| 20090287245 | Ostrovsky et al. | Nov 2009 | A1 |
| 20090299407 | Yuan et al. | Dec 2009 | A1 |
| 20090299408 | Schuldt-Hempe et al. | Dec 2009 | A1 |
| 20090306710 | Lindh et al. | Dec 2009 | A1 |
| 20090318958 | Ochiai | Dec 2009 | A1 |
| 20100021516 | McKay | Jan 2010 | A1 |
| 20100023055 | Rousseau | Jan 2010 | A1 |
| 20100057123 | D'Agostino et al. | Mar 2010 | A1 |
| 20100063540 | Maiorino | Mar 2010 | A1 |
| 20100071833 | Maiorino | Mar 2010 | A1 |
| 20100087855 | Leung et al. | Apr 2010 | A1 |
| 20100101707 | Maiorino et al. | Apr 2010 | A1 |
| 20100146770 | Morency et al. | Jun 2010 | A1 |
| 20100160961 | Nawrocki et al. | Jun 2010 | A1 |
| 20100163056 | Tschopp et al. | Jul 2010 | A1 |
| 20100211097 | Hadba et al. | Aug 2010 | A1 |
| 20100211098 | Hadba et al. | Aug 2010 | A1 |
| 20100230300 | Hunter et al. | Sep 2010 | A1 |
| 20100239635 | McClain et al. | Sep 2010 | A1 |
| 20100292718 | Sholev et al. | Nov 2010 | A1 |
| 20100294103 | Genova et al. | Nov 2010 | A1 |
| 20100294104 | Genova et al. | Nov 2010 | A1 |
| 20100294105 | Genova et al. | Nov 2010 | A1 |
| 20100294106 | Genova et al. | Nov 2010 | A1 |
| 20100294107 | Genova et al. | Nov 2010 | A1 |
| 20100298637 | Ruff | Nov 2010 | A1 |
| 20100298639 | Leung et al. | Nov 2010 | A1 |
| 20100298848 | Leung et al. | Nov 2010 | A1 |
| 20100298867 | Ruff | Nov 2010 | A1 |
| 20100298868 | Ruff | Nov 2010 | A1 |
| 20100298871 | Ruff et al. | Nov 2010 | A1 |
| 20100298874 | Leung et al. | Nov 2010 | A1 |
| 20100298875 | Leung et al. | Nov 2010 | A1 |
| 20100298876 | Leung et al. | Nov 2010 | A1 |
| 20100298878 | Leung et al. | Nov 2010 | A1 |
| 20100298879 | Leung et al. | Nov 2010 | A1 |
| 20100298880 | Leung et al. | Nov 2010 | A1 |
| 20100313723 | Genova et al. | Dec 2010 | A1 |
| 20100313729 | Genova et al. | Dec 2010 | A1 |
| 20100313730 | Genova et al. | Dec 2010 | A1 |
| 20100318122 | Leung et al. | Dec 2010 | A1 |
| 20100318123 | Leung et al. | Dec 2010 | A1 |
| 20100318124 | Leung et al. | Dec 2010 | A1 |
| 20110009902 | Leung et al. | Jan 2011 | A1 |
| 20110022086 | D'Agostino et al. | Jan 2011 | A1 |
| 20110046668 | Goraltchouk et al. | Feb 2011 | A1 |
| 20110046669 | Goraltchouk et al. | Feb 2011 | A1 |
| 20110093010 | Genova et al. | Apr 2011 | A1 |
| 20110106152 | Kozlowski | May 2011 | A1 |
| 20110125188 | Goraltchouk et al. | May 2011 | A1 |
| 20110130774 | Criscuolo et al. | Jun 2011 | A1 |
| 20110166597 | Herrmann et al. | Jul 2011 | A1 |
| 20110264138 | Avelar et al. | Oct 2011 | A1 |
| 20110288583 | Goraltchouk et al. | Nov 2011 | A1 |
| 20110319932 | Avelar et al. | Dec 2011 | A1 |
| 20120101522 | Megaro et al. | Apr 2012 | A1 |
| 20120109188 | Viola | May 2012 | A1 |
| 20130072971 | Kim et al. | Mar 2013 | A1 |
| 20130103078 | Longo et al. | Apr 2013 | A1 |
| 20130165971 | Leung et al. | Jun 2013 | A1 |
| 20130172931 | Gross et al. | Jul 2013 | A1 |
| 20130180966 | Gross et al. | Jul 2013 | A1 |
| 20130204295 | Hunter et al. | Aug 2013 | A1 |
| 20130226234 | Avelar et al. | Aug 2013 | A1 |
| 20130238021 | Gross et al. | Sep 2013 | A1 |
| 20130238022 | Gross et al. | Sep 2013 | A1 |
| 20130245684 | Ruff et al. | Sep 2013 | A1 |
| 20130317545 | Gross et al. | Nov 2013 | A1 |
| Number | Date | Country |
|---|---|---|
| 1014364 | Sep 2003 | BE |
| 2309844 | Dec 1996 | CA |
| 2640420 | Sep 2004 | CN |
| 01810800 | Jun 1970 | DE |
| 03227984 | Feb 1984 | DE |
| 04302895 | Aug 1994 | DE |
| 19618891 | Apr 1997 | DE |
| 19833703 | Feb 2000 | DE |
| 10245025 | Apr 2004 | DE |
| 102005004317 | Jun 2006 | DE |
| 0121362 | Sep 1987 | EP |
| 0329787 | Aug 1989 | EP |
| 0513713 | May 1992 | EP |
| 0428253 | Jul 1994 | EP |
| 0632999 | Jan 1995 | EP |
| 0513736 | Feb 1995 | EP |
| 0464479 | Mar 1995 | EP |
| 0464480 | Mar 1995 | EP |
| 0576337 | Mar 1997 | EP |
| 0576337 | Mar 1997 | EP |
| 0574707 | Aug 1997 | EP |
| 0612504 | Nov 1997 | EP |
| 0558993 | Apr 1998 | EP |
| 0913123 | May 1999 | EP |
| 0916310 | May 1999 | EP |
| 0664198 | Jun 1999 | EP |
| 0960600 | Dec 1999 | EP |
| 0705567 | Mar 2002 | EP |
| 0673624 | Aug 2002 | EP |
| 0839499 | Sep 2003 | EP |
| 0755656 | Dec 2003 | EP |
| 1075843 | Feb 2005 | EP |
| 1525851 | Apr 2005 | EP |
| 1532942 | May 2005 | EP |
| 0826337 | Dec 2005 | EP |
| 0991359 | Nov 2007 | EP |
| 2036502 | Mar 2009 | EP |
| 1948261 | Nov 2010 | EP |
| 2245992 | Nov 2010 | EP |
| 1726317 | Jul 2012 | EP |
| 2619129 | Feb 1989 | FR |
| 2693108 | Jan 1994 | FR |
| 0267007 | Mar 1927 | GB |
| 1091282 | Nov 1967 | GB |
| 1428560 | Jul 1973 | GB |
| 1506362 | Apr 1978 | GB |
| 1508627 | Apr 1978 | GB |
| 1506362 | Apr 1978 | JP |
| 54-116419 | Sep 1979 | JP |
| 63-288146 | Nov 1988 | JP |
| 001113091 | May 1989 | JP |
| 3-165751 | Jul 1991 | JP |
| 4-096758 | Mar 1992 | JP |
| 4-266749 | Sep 1992 | JP |
| 9-103477 | Apr 1997 | JP |
| 410085225 | Apr 1998 | JP |
| H10-286258 | Oct 1998 | JP |
| H10-337291 | Dec 1998 | JP |
| 11-313826 | Nov 1999 | JP |
| 011332828 | Dec 1999 | JP |
| 2002-059235 | Feb 2002 | JP |
| 2003-275217 | Sep 2003 | JP |
| 2006-522656 | Oct 2006 | JP |
| 2009-118967 | Jun 2009 | JP |
| 2009-247900 | Oct 2009 | JP |
| 10-2005-0072908 | Jul 2005 | KR |
| 6013299 | Feb 2006 | KR |
| 501224 | Mar 2002 | NZ |
| 531262 | Dec 2005 | NZ |
| 2139690 | Oct 1999 | RU |
| 2175855 | Nov 2001 | RU |
| 2241389 | Dec 2004 | RU |
| 2268752 | Jan 2006 | RU |
| 1745214 | Jul 1992 | SU |
| 1752358 | Aug 1992 | SU |
| WO 1996006565 | Mar 1966 | WO |
| WO 1986000020 | Jan 1986 | WO |
| WO 1987001270 | Mar 1987 | WO |
| WO 1988009157 | Dec 1988 | WO |
| WO 1989005618 | Jun 1989 | WO |
| WO 1990009149 | Aug 1990 | WO |
| WO 1990014795 | Dec 1990 | WO |
| WO 1992022336 | Dec 1992 | WO |
| WO 1995016399 | Jun 1995 | WO |
| WO 1995029637 | Nov 1995 | WO |
| WO 1997000047 | Jan 1997 | WO |
| WO 1998052473 | Nov 1998 | WO |
| WO 1998055031 | Dec 1998 | WO |
| WO 1999021488 | May 1999 | WO |
| WO 1999033401 | Jul 1999 | WO |
| WO 1999052478 | Oct 1999 | WO |
| WO 1999059477 | Nov 1999 | WO |
| WO 1999062431 | Dec 1999 | WO |
| WO 2000051658 | Sep 2000 | WO |
| WO 2000051685 | Sep 2000 | WO |
| WO 2001006952 | Feb 2001 | WO |
| WO 2001056626 | Aug 2001 | WO |
| WO 2003001979 | Jan 2003 | WO |
| WO 2003003925 | Jan 2003 | WO |
| WO 2003045255 | Jun 2003 | WO |
| WO 2003077772 | Sep 2003 | WO |
| WO 2003092758 | Nov 2003 | WO |
| WO 2003103733 | Dec 2003 | WO |
| WO 2003103972 | Dec 2003 | WO |
| WO 2003105703 | Dec 2003 | WO |
| WO 2004014236 | Feb 2004 | WO |
| WO 2004030517 | Apr 2004 | WO |
| WO 2004030520 | Apr 2004 | WO |
| WO 2004030704 | Apr 2004 | WO |
| WO 2004030705 | Apr 2004 | WO |
| WO 2004062459 | Jul 2004 | WO |
| WO 2004100801 | Nov 2004 | WO |
| WO 2004112853 | Dec 2004 | WO |
| WO 2005016176 | Feb 2005 | WO |
| WO 2005074913 | Aug 2005 | WO |
| WO 2005096955 | Oct 2005 | WO |
| WO 2005096956 | Oct 2005 | WO |
| WO 2005112787 | Dec 2005 | WO |
| WO 2006005144 | Jan 2006 | WO |
| WO 2006012128 | Feb 2006 | WO |
| WO 2006037399 | Apr 2006 | WO |
| WO 2006061868 | Jun 2006 | WO |
| WO 2006079469 | Aug 2006 | WO |
| WO 2006082060 | Aug 2006 | WO |
| WO 2006099703 | Sep 2006 | WO |
| WO 2006138300 | Dec 2006 | WO |
| WO 2007005291 | Jan 2007 | WO |
| WO 2007005296 | Jan 2007 | WO |
| WO 2007038837 | Apr 2007 | WO |
| WO 2007053812 | May 2007 | WO |
| WO 2007089864 | Aug 2007 | WO |
| WO 2007112024 | Oct 2007 | WO |
| WO 2007133103 | Nov 2007 | WO |
| WO 2007145614 | Dec 2007 | WO |
| WO 2008128113 | Oct 2008 | WO |
| WO 2008150773 | Dec 2008 | WO |
| WO 2009042841 | Apr 2009 | WO |
| WO 2009068252 | Jun 2009 | WO |
| WO 2009087105 | Jul 2009 | WO |
| WO 2009097556 | Aug 2009 | WO |
| WO 2009149455 | Dec 2009 | WO |
| WO 2009151876 | Dec 2009 | WO |
| WO 2010052007 | May 2010 | WO |
| WO 2010107698 | Sep 2010 | WO |
| WO 2011053375 | May 2011 | WO |
| WO 2011090628 | Jul 2011 | WO |
| WO 2011139916 | Nov 2011 | WO |
| WO 2011140283 | Nov 2011 | WO |
| Entry |
|---|
| US 8,663,276 B2, 03/2014, Leung et al. (withdrawn) |
| International Search Report for PCT/US2012/030441 dated Sep. 27, 2012. |
| Communication from EPO re: 10000486 dated Apr. 4, 2011, 4 pages. |
| European Search Report re: EP05025816 dated Jun. 23, 2006. |
| European Search Report for EP07006258.3 dated May 4, 2007, 4 pages. |
| European Search Report for EP07015906 dated Oct. 2, 2007. |
| European Search Report for EP07015905.8 dated Oct. 2, 2007, 2 pages. |
| European Search Report for EP07016222 dated Jan. 7, 2008. |
| European Search Report for EP09014651 dated Jan. 12, 2010. |
| European Search Report for EP10000629.5 dated Mar. 10, 2010, 4 pages. |
| European Search Report re: EP10000486 dated Apr. 23, 2010. |
| European Search Report re: 10004453 dated Jun. 15, 2010. |
| European Search Report for EP10011871.0 dated Dec. 3, 2010, 2 pages. |
| European Search Report for EP10011868.6 dated Dec. 6, 2010, 2 pages. |
| European Search Report for EP10011869 dated Jan. 20, 2011. |
| European Search Report for EP10011872 dated Apr. 20, 2011. |
| European Search Report for EP10012437 dated Apr. 28, 2011. |
| European Search Report for EP10186592.1 dated Jan. 19, 2011, 2 pages. |
| European Search Report for EP10184766 dated Apr. 20, 2011. |
| Extended European Search Report re: 07015905.8 dated Oct. 23, 2007. |
| Extended European Search Report re: 07016222.7 dated Jan. 30, 2008. |
| International Preliminary Examination Report re: PCT/US1998/10478 dated Dec. 11, 1999. |
| International Preliminary Report re: PCT/US2007/002688 dated Aug. 14, 2008. |
| International Preliminary Report re: PCT/US2008/060127 dated Oct. 13, 2009. |
| International Preliminary Report re: PCT/US2008/087788 dated Jun. 22, 2010. |
| International Preliminary Report re: PCT/US2009/032693 dated Aug. 3, 2010. |
| International Preliminary Report re: PCT/US2009/040545 dated Oct. 19, 2010. |
| International Preliminary Report re: PCT/US2009/041685 dated Oct. 26, 2010. |
| International Preliminary Report re: PCT/US2009/044274 dated Nov. 17, 2010. |
| International Preliminary Report re: PCT/US2011/035431 dated Nov. 6, 2012. |
| International Preliminary Report re: PCT/US2011/059238 dated May 7, 2013. |
| International Search Report for PCT/US1994/09631 dated Dec. 9, 1994. |
| International Search Report for PCT/US1998/10478 dated Sep. 23, 1998. |
| International Search Report for PCT/US2002/20449 dated May 20, 2003. |
| International Search Report for PCT/US2002/027525 dated Dec. 9, 2002, 3 pages. |
| International Search Report for PCT/US2003/030424 dated Nov. 1, 2004. |
| International Search Report for PCT/US2003/030664 dated May 25, 2004. |
| International Search Report for PCT/2003/030666 dated Dec. 15, 2004. |
| International Search Report for PCT/US2003/025088 dated Dec. 29, 2003. |
| International Search Report re: PCT/US2003/030674 dated Sep. 2, 2004. |
| International Search Report re: PCT/US2004/014962 dated Feb. 24, 2005. |
| International Search Report for PCT/US2005/017028 dated Mar. 26, 2008. |
| International Search Report for PCT/US2007/002688 dated Oct. 22, 2007. |
| International Search Report for PCT/US2007/074658 dated Jun. 12, 2007, 3 pages. |
| International Search Report for PCT/US2008/060127 dated Sep. 23, 2008, 5 pages. |
| International Search Report for PCT/US2008/077813 dated Mar. 31, 2009. |
| International Search Report for PCT/US2008/082009 dated Feb. 16, 2010. |
| International Search Report for PCT/US2009/032693 dated Aug. 26, 2009. |
| International Search Report for PCT/US2009/034703 dated Sep. 28, 2009. |
| International Search Report for PCT/US2009/040545 dated Oct. 29, 2009. |
| International Search Report for PCT/US2009/063081 dated Aug. 2, 2010. |
| International Search Report for PCT/US2009/041685 dated Dec. 22, 2009. |
| International Search Report for PCT/US2009/044274 dated Jan. 15, 2010. |
| International Search Report for PCT/US2010/056898 dated Aug. 2, 2011. |
| International Search Report for PCT/US2010/060889 dated Oct. 11, 2011. |
| International Search Report for PCT/US2011/034660 dated Feb. 8, 2012. |
| International Search Report for PCT/US2011/035270 dated Jan. 12, 2012. |
| International Search Report for PCT/US2011/035271 dated Jan. 12, 2012. |
| International Search Report re: PCT/US2011/035431 dated Jan. 12, 2012. |
| International Search Report for PCT/US2011/059238 dated May 21, 2012. |
| International Search Report for PCT/US2012/041001 dated Sep. 26, 2012. |
| Partial European Search Report re: EP05025816 dated Mar. 20, 2006. |
| Singapore Search Report for Singapore Patent Application No. 200702625-5 dated Nov. 26, 2008, 7 pages. |
| Singapore Search Report for Singapore Patent Application No. 200702350-0 dated Nov. 26, 2008, 6 pages. |
| Singapore Search Report for Singapore Patent Application No. 200703688-2 dated Nov. 26, 2008, 7 pages. |
| Singapore Search Report for Singapore Patent Application No. 201103117-6 dated Mar. 8, 2013. |
| Supplementary European Search Report re: EP98923664 dated Jun. 12, 2001. |
| Supplementary European Search Report re: EP03752630 dated Nov. 17, 2005. |
| Supplementary European Search Report re: 03770556 dated Nov. 17, 2005. |
| Supplementary European Search Report re: 03754965 dated Nov. 18, 2005. |
| Supplementary European Search Report re: EP03785177 dated May 19, 2009. |
| Supplementary European Search Report re: 05750101 dated Apr. 7, 2010. |
| Supplementary European Search Report re: 07017663 dated Nov. 7, 2007. |
| Bacci, Pier Antonio, “Chirurgia Estetica Mini Invasiva Con Fili Di Sostegno”, Collana di Arti, Pensiero e Scienza; Minelli Editore—2006; 54 pgs. |
| Behl, Marc et al., “Shape-Memory Polymers”, Materials Today Apr. 2007; 10(4); 20-28. |
| Belkas, J. S. et al., “Peripheral nerve regeneration through a synthetic hydrogel nerve tube”, Restorative Neurology and Neuroscience 23 (2005) 19-29. |
| Bellin, I. et al., “Polymeric triple-shape materials”, Proceedings of the National Academy of Sciences of the United States of America Nov. 28, 2006; 2103(48):18043-18047. |
| Boenisch, U.W. et al ‘Pull-Out strength and stiffness of meniscal repair using absorbable arrows or Ti-Cron vertical and horizontal loop sutures’ American Journal of Sports Medicine, Sep.-Oct. (1999) vol. 27, Issue 5, pp. 626-631. |
| Buckley, P.R. ‘Actuation of Shape Memory Polymer using Magnetic Fields for Applications in Medical Devices’ Master of Science in Mechanical Engineering in Massachusetts Institute of Technology Jun. 2003, 144 pages. |
| Buncke, Jr., H.J. et al ‘The Suture Repair of One-Millimeter Vessels, microvascular surgery’ (1966) Report of First Conference; Oct. 6-7, pp. 24-35. |
| Bunnell, S. ‘Gig pull-out suture for tendons’ J Bone Joint Surg. Am (1954) vol. 36A, No. 4 pp. 850-851. |
| CCPR Centro De Cirurgia Plastica e Reabilitacao Up Lifting (Aptos Threads) http://ccpr.com.br/upl-l.htm, Aug. 19, 2002 pp. 1-2. |
| Dahlin, Lars, “Techniques of Peripheral Nerve Repair”, Scandinavian Journal of Surgery 97: 310-316, 2008. |
| Datillo, Jr., P.P. ‘Knotless Bi-directional Barbed Absorbable Surgical Suture’ Dissertation submitted to the Graduate Faculty of North Carolina State University Textile Management and Technology Nov. 2002, 75 pages. |
| Datillo, Jr. P.P. et al ‘Medical Textiles: Application of an Absorbable Barbed Bi-Directional Surgical Suture’ (2002) The Journal of Textile and Apparel Technology and Management vol. 2, Issue 2, pp. 1-5. |
| Datillo, Jr., P. et al ‘Tissue holding performance of knotless absorbable sutures’ Society for Biomaterials 29th Annual Meeting Transactions (2003) p. 101. |
| Declaration of Dr. Gregory L. Ruff, dated Aug. 19, 2005, 8 pages, with Exhibits A-E. |
| De Persia, Raúl et al., “Mechanics of Biomaterials: Sutures After the Surgery”, Applications of Engineering Mechanics in Medicine, GED—University of Puerto Rico, Mayaguez May 2005, p. F1-F27. |
| Delorenzi, C.L., “Barbed Sutures: Rationale and Technique”, Aesthetic Surg. J. Mar. 26, 2006(2): 223-229. |
| Demyttenaere, Sebastian V. et al., “Barbed Suture for Gastrointestinal Closure: A Randomized Control Trial”, Surgical Innovation; vol. 16, No. 3; Sep. 2009; pp. 237-242. |
| Einarsson, Jon I. et al., “Barbed Suture, now in the toolbox of minimally invasive gyn surgery”, OBG Management; vol. 21, No. 9; Sep. 2009; pp. 39-41. |
| Gross, Alex, “Physician perspective on thread lifts”, Dermatology Times Feb. 27, 2006(2): 2 pages. |
| Gross, R.A. et al ‘Biodegradable Polymers for the Environment’ Science (2002) vol. 297, Issue 5582 pp. 803. |
| Han, H. et al ‘Mating and Piercing Micromechanical Suture for Surface Bonding Applications’ (1991) Proceedings of the 1991 Micro Electro Mechanical Systems (MEMS>91), An Investigation of Micro Structures, Sensors, Actuators, Machines and Robots pp. 253-258. |
| Ingle, N.P. et al ‘Barbed Suture Anchoring Strength: Applicability to Dissimilar Polymeric Materials’ College of Textiles, North Carolina State University, 7th World Biomaterials Congress 2004, 1 page. |
| Ingle, N.P. et al ‘Mechanical Performance and Finite Element Analysis of Bi-directional Barbed Sutures’ Master of Science in Textile Technology & Management at North Carolina State University Aug. 2003, 126 pages. |
| Ingle, N.P. et al., “Optimizing the tissue anchoring performance of barbed sutures in skin and tendon tissues”, Journal of Biomechanics 43 (2010); pp. 302-309. |
| Ingle, Nilesh P et al., “Testing the Tissue-holding Capacity of Barbed Sutures”, College of Textiles, North Carolina State University, Fiber Science, The Next Generation Oct. 17-19, 2005, New Jersey Institute of Technology, Newark, NJ, 4 pages. |
| Jennings et al ‘A New Technique in primary tendon repair’ Surg. Gynecol. Obstet. (1952) vol. 95, No. 5 pp. 597-600. |
| Jeong, H.E. et al ‘A nontransferring dry adhesive with hierarchial polymer nanohairs’ PNAS 106 (14) pp. 5639-5644 (2009). |
| Kaminer, M. et al., “ContourLift™: A New Method of Minimally Invasive Facial Rejuvenation”, Cosmetic Dermatology Jan. 2007;20(1):29-35. |
| Kelch et al., “Shape-memory Polymer Networks from Olio [(ϵ-hydroxycaproate)-co-glycolate]dimethacrylates and Butyl Acrylate with Adjustable Hydrolytic Degradation Rate”, Biomacromolecules 2007;8(3):1018-1027. |
| Khademhosseini, Ali et al., “Nanobiotechnology Drug Delivery and Tissue Engineering”, Chemical Engineering Progress 102:38-42 (2006). |
| Kuniholm J.F. et al ‘Automated Knot Tying for Fixation in Minimally Invasive, Robot Assisted Cardiac Surgery’ Master of Science in Mechanical & Aerospace Engineering at North Carolina State University May 2003, 71 pages. |
| Lendlein, A. et al ‘Biodegradable, Elastic Shape-Memory Polymers for Potential Biomedical Applications’ (2002) Science vol. 296 pp. 1673-1676. |
| Lendlein, A. et al ‘Shape-Memory Polymers’ Agnew Chem. Int. Ed. (2002) vol. 41 pp. 2034-2057. |
| Leung, J. et al ‘Barbed, Bi-directional Medical Sutures: Biomechanical Propertics and Wound Closure Efficacy Study’ 2002 Society for Biomaterials 28th Annual Meeting Transactions 1 page. |
| Leung, J. et al ‘Barbed, Bi-directional Surgical Sutures’ International Conference & Exhibition on Healthcare & Medical Textiles, Jul. 8-9, 2003 pp. 1-8. |
| Leung, J. et al ‘Barbed, Bi-directional Surgical Sutures: In Vivo Strength and Histopathology Evaluations’ 2003 Society for Biomaterials 29th Annual Meeting Transactions pp. 100. |
| Leung, J. et al., “Barbed Suture Technology: Recent Advances”, Medical Textiles 2004, Advances in Biomedical Textiles and Healthcare Products, Conference Proceedings, IFAI Expo 2004, Oct. 26-27, 2004, Pittsburgh, PA., pp. 62-80. |
| Leung, J. et al ‘Performance Enhancement of a Knotless Suture via Barb Geometry Modifications’ 7th World Biomaterials Congress 2004, 1 page. |
| Li, Y.Y. et al ‘Polymer Replicas of Photonic Porous Silicon for Sensing and Drug Delivery Applications’ (2003) Science vol. 299 pp. 2045-2047. |
| Liu, Changdeng et al., “Shape Memory Polymer with Improved Shape Recovery”, Mater. Res. Soc. Symp. Proc. vol. 855E, 2005 Materials Research Society, pp. W4.7.1-W4.7.6. |
| Madduri, Srinivas, et al., “Neurotrophic factors release from nerve conduits for peripheral axonal regeneration”, European Cells and Materials vol. 16; Suppl. 1 (2008), p. 14. |
| Madhave et al ‘A biodegradable and biocompatible gecko-inspired tissue adhesive’ PNAS 105(7) pp. 2307-2312 (2008). |
| Maitland et al., “Prototype laser-activated shape memory polymer foam device for embolic treatment of aneurysms”, Journal of Biomedical Optics May/Jun. 2007;12(3): pp. 030504-1 to 030504-3. |
| Malina, M. et al ‘Endovascular AAA Exclusion: Will Stents with Hooks and Barbs Prevent Stent-Graft Migration’ Journal Endovascular Surgery (1998) vol. 5 pp. 310-317. |
| Mansberger et al ‘A New Type Pull-Out Wire for Tendon Surgery: A Preliminary Report’ Department of Surgery, University I Iospital and University of Maryland School of Medicine, Baltimore, Maryland, Received for Publication May 10, 1951 pp. 119-121. |
| Martin, D.P. et al ‘Medical applications of poly-4-hydroxybutyrate: a strong flexible absorbable biomaterial’ Biochemical Engineering Journal vol. 16 (2003) pp. 97-105. |
| Mason, M.L. ‘Primary and Secondary Tendon Suture. A discussion of the significance of technique in tendon surgery’ (1940) Surg Gynecol Obstet 70. |
| McKee, GK ‘Metal anastomosis tubes in tendon suture’ The Lancet (1945) pp. 659-660. |
| McKenzie ‘An Experimental Multiple Barbed Suture for the Long Flexor Tendons of the Palm and Fingers’ The Journal of Bone and Joint Surgery (1967) vol. 49B, No. 3 pp. 440-447. |
| Middleton and Tipton ‘Synthetic Biodegradable Polymers as Medical Devices’ (1998) Medical Plastics and Biomaterials Magazine, 9 pages. |
| Moran et al., “Bidirectional-Barbed Sutured Knotless Running Anastomosis v Classic van Velthovan in a Model System”, Journal of Endourology Oct. 2007; 21(10); 1175-1177. |
| Mullner, “Metal Foam Has a Good Memory”, Dec. 18, 2007 Original story at <http://www.physorg.com/news117214996.html>. |
| Murtha et al., “Evaluation of a Novel Technique for Wound Closure Using a Barbed Suture”, Journal of the American Society of Plastic Surgeons 2006; 117(6); 1769-1780. |
| Nie, Zhihong and Kumacheva, Eugenia, “Patterning surfaces with functional polymers”, Nature Materials vol. 7(2008): 277-290. |
| Paul, Malcolm D., “Bidirectional Barbed Sutures for Wound Closure: Evolution and Applications”, Journal of the American College of Certified Wound Specialists (2009) 1, 51-57. |
| Paul, Malcolm D. and Rui Avelar, “Quill™ SRS Techniques & Procedures A Novel Approach to Soft Tissue Approximation”, Canada, Angiotech Pharmaceuticals, Inc., First Edition Aug. 2007: 20 pages. |
| Paul, Malcolm D. and Rui Avelar, “Quill™ SRS Techniques & Procedures A Novel Approach to Soft Tissue Approximation”, Canada, Angiotech Pharmaceuticals, Inc., Second Edition Aug. 2008: 20 pages. |
| Paul, Malcolm D. and Rui Avelar, “Quill™ SRS Techniques & Procedures A Novel Approach to Soft Tissue Approximation”, Canada, Angiotech Pharmaceuticals, Inc., Third Edition 2009, 8 2007-2009: 27 pages. |
| Paul, Malcolm D. and Rui Avelar, “Quill™ SRS Techniques & Procedures A Novel Approach to Soft Tissue Approximation”, Canada, Angiotech Pharmaceuticals, Inc., Fourth Edition 2010, 8 2007-2010: 27 pages. |
| Paul, Malcolm D., “Using Barbed Sutures in Open/Subperiosteal Midface Lifting”, Aesthetic Surgery Journal 2006(26): 725-732. |
| Potenza, A. ‘Tendon Healing Within the Flexor Digital Sheath in the Dog: An Experimental Study’ Journal of Bone & Joint Surgery (1962) vol. 44A No. 1 pp. 49-64. |
| Pulvertaft ‘Suture Materials and Tendon Junctures’ American Journal of Surgery (1965) vol. 109 pp. 346-352. |
| Quill Medical, Inc. ‘Barbed Sutures, wrinkle filters give patients more innovative, non-surgical options’ Press Release of Program presented at American Society of Plastic Surgeons annual scientific meeting; Philadelphia, Oct. 9, 2004 3 pages. |
| Quill Medical, Inc. ‘Quill Medical's Novel-Self-Anchoring Surgical Suture Approved for Sale in Europe’ Press Release; Research Triangle Park, N.C. May 10, 2004, 1 page. |
| Quill Medical, Inc., “Quill Medical, Inc. Receives FDA Clearance for First-in-Class Knot-Less Self-Anchoring Surgical Suture”, Press Release; Research Triangle Park, N.C., Nov. 4, 2004, 1 page. |
| Richert, Ludovic, et al., “Surface Nanopatterning to Control Cell Growth”, Advanced Materials 2008(15): 1-5. |
| Rodeheaver, G.T. et al., “Barbed Sutures for Wound Closure: In Vivo Wound Security, Tissue Compatibility and Cosmesis Measurements”, Society for Biomaterials 30th Annual Meeting Transactions, 2005, 2 pages. |
| Rofin-Baasel ‘Laser Marking on Plastic Materials’ (2001) RB50.0, Rofin-Baasel Inc. 2 pages. |
| Ruff, Gregory, “Technique and Uses for Absorbable Barbed Sutures”, Aesthetic Surgery Journal Sep./Oct. 2006; 26:620-628. |
| Scherrnan, Peter et al., “Sutures as longitudinal guides for the repair of nerve defects—Influence of suture numbers and reconstruction of nerve bifurcations”, Restorative Neurology and Neuroscience 23 (2005) 79-85. |
| Schmid A. et al ‘The outspreading anchor cord. A material for arthroscopic suturing of a fresh anterior cruciate ligament rupture’ Surgical Clinic of the University of Gottingen (1987) pp. 417-426. |
| Semenov, G.M. et al ‘Surgical Suture’ (2001) Piter, Saint Petersburg, pp. 12-13 and 92-98. |
| Serafetinides, AA ‘Short pulse laser beam interactions with polymers biocompatible materials and tissue’ Proce SPIE vol. 3052 (1996) pp. 111-123. |
| Sulamanidze, M. et al., “APTOS Suture Lifting Methods: 10 Years of Experience”, Clin Plastic Surg 36 (2009); pgs. 281-306. |
| Sulamanidze, M.A. et al ‘Clinical aspects of bloodless facelift using APTOS filaments’ A.V. Vishnevsky Institute of Surgery, Bol'shaya Scrpukhovskaya ul, 7, 113811, Moscow, Russia (2002) pp. 24-34. |
| Sulamanidze, M.A. et al ‘Facial lifting with Aptos threads’ International Journal of Cosmetic Surgery and Aesthetic Dermatology (2001) No. 4 pp. 1-8. |
| Sulamanidze, M.A. et al ‘Management of Facial Rhytids by Subcutaneous Soft Tissue Dissection’ (2000) International Journal of Cosmetic Surgery and Aesthetic Dermatology vol. 2 No. 4 pp. 255-259. |
| Sulamanidze, M.A. et al ‘Morphological foundations of facelift using APTOS filaments’ Bolshaya Serpukhovskaya ul 27, 113811 Moscow, Russia (2002) pp. 19-26. |
| Sulamanidze, M.A. et al ‘Removal of Facial Soft Tissue Ptosis with Special Threads’ Dermatol Surg (2002) vol. 28 pp. 367-371. |
| Sulamanidze, MD, M.A., et al., “Soft tissue lifting in the mid-face: old philosophy, new approach—internal stitching technique (APTOS Needle)”, Plastic and Aesthetic Surgery Clinic Total Sharm, Moscow, Russia, (2005):15-29. |
| Sulzle, Inc. B.G. et al Drilled End Surgical Needles Jul. 2002 Syracuse, New York. |
| Surgical Specialties Corporation, “Wound Closure Catalog”; Summer 2005, 5 pages. |
| Szarmach, R. et al ‘An Expanded Surgical Suture and Needle Evaluation and Selection Program by a Healthcare Resource Management Group Purchasing Organization’ Journal of Long-Term Effects of Medical Implants (2003) vol. 13 No. 3 pp. 155-170. |
| Verdan, C. ‘Primary Repair of Flexor Tendons’ Journal of Bone and Joint Surgery (1960) vol. 42, No. 4 pp. 647-657. |
| Villa, Mark T. et al., “Barbed Sutures: A Review of Literature”, Plastic and Reconstructive Surgery; Mar. 2008; vol. 121, No. 3; pp. 102e-108e. |
| Wu. W. ‘Barbed Sutures in Facial Rejuvenation’ Aesthetic Surgery Journal (2004) vol. 24 pp. 582-587. |
| Zoltan, J. ‘Cicatrix Optimia: Techniques for Ideal Wound Healing’ English language edition University Park Press Baltimore (1977) Chapter 3 pp. 54-55. |
| Supplementary European Search Report re: 12760468 dated Jul. 10, 2014. |
| Australian Office Action, Patent Examination Report No. 1, dated Sep. 30, 2015 for Application No. AU 2012230716, 4 pgs. |
| Canadian Office Action dated Mar. 5, 2018 for Application No. CA 2,830,961, 4 pgs. |
| Chinese Office Action, The First Office Action, and Search Report dated Aug. 27, 2015 for Publication No. CN 201280025020.3, 10 pgs. |
| Chinese Office Action, The Second Office Action, dated Apr. 28, 2016 for Publication No. CN 201280025020.3, 7 pgs. |
| Europe Exam Report dated Aug. 11, 2015 for Application No. EP 12760468.4, 6 pgs. |
| Japanese Office Action, Decision of Refusal, dated Aug. 23, 2016 for Application No. JP 2014-501287, 2 pgs. |
| Japanese Office Action, Decision to Grant a Patent, dated Mar. 14, 2017 for Application No. JP 2014-501287, 3 pgs. |
| Japanese Office Action, Decision to Grant a Patent, dated Jul. 31, 2018 for Application No. JP 2016-249200, 3 pgs. |
| Japanese Office Action, Notification of Reasons for Refusal, and Search Report dated Nov. 21, 2017 for Application No. JP 2016-249200, 16 pgs. |
| Japanese Office Action, Notification of Reasons for Refulsal, and Search Report dated Dec. 15, 2015 for Application No. JP 2014-501287, 68 pgs. |
| International Search Report and Written Opinion dated Sep. 27, 2012 for Application No. PCT/US2012/030441, 5 pages. |
| International Preliminary Report on Patentability and Written Opinion dated Sep. 24, 2013 for Application No. PCT/US2012/030441, 6 pgs. |
| Chinese Search Report, Supplementary, dated Aug. 31, 2016 for Application No. CN 201280025020.3, 1 pg. |
| European Office Action, Decision to Grant, dated Jan. 5, 2017 for Application No. EP 127060468.4, 2 pgs. |
| Mexican Office Action dated Jul. 28, 2015 for Application No. MX/a/2013/010899, 4 pgs. |
| Russian Office Action dated Mar. 21, 2016 for Application No. RU 2013147159/14, 3 pgs. |
| U.S. Appl. No. 61/329,436. |
| U.S. Appl. No. 61/466,924, filed Mar. 23, 2011, by Gross et al., titled: “Self-Retaining Variable Loop Sutures.”. |
| Number | Date | Country | |
|---|---|---|---|
| 20120245629 A1 | Sep 2012 | US |
| Number | Date | Country | |
|---|---|---|---|
| 61466924 | Mar 2011 | US |
